lxrp_10q.htm

0001640334-20-000022.txt : 20200109 0001640334-20-000022.hdr.sgml : 20200109 20200108184041 ACCESSION NUMBER: 0001640334-20-000022 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20191130 FILED AS OF DATE: 20200109 DATE AS OF CHANGE: 20200108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-52138 FILM NUMBER: 20516753 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 10-Q 1 lxrp_10q.htm FORM 10-Q lxrp_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2019

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number _______________

LEXARIA BIOSCIENCE CORP.
(Exact name of registrant as specified in its charter)

Nevada		20-2000871
State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)

#100 – 740 McCurdy Road, Kelowna BC Canada		V1X 2P7
(Address of principal executive offices)		(Zip Code)

Registrant’s Telephone number, including area code: 250-765-6424

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Name of Each Exchange On Which Registered
N/A

N/A

Securities registered pursuant to Section 12(g) of the Act:

Title of Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $0.001

LXRP

LXX

OTCQX

CSE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
¨
Accelerated filer
x
Non-accelerated filer
¨
Smaller reporting company
x

Emerging growth company
¨

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date.

80,720,879 common shares as of January 8, 2020

DOCUMENTS INCORPORATED BY REFERENCE

None.

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION.

Item 1.
Financial Statements.

3

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.

15

Item 3.
Controls and Procedures.

20

PART II—OTHER INFORMATION.

Item 1.
Legal Proceedings.

22

Item 1A.
Risk Factors.

22

Item 15.
Exhibits, Financial Statement Schedules.

23

Page 2 of 24

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED BALANCE SHEET
(Expressed in U.S. Dollars)

November 30

August 31

2019

2019

ASSETS

(UnAudited)

(Audited)

Current

Cash and cash equivalents

$ 1,333,321

$ 1,285,147
Marketable Securities (Note 19)

22,640

64,214
Accounts receivable (Note 7)

325,901

273,145
Inventory (Note 8)

133,556

127,396
Prepaid expenses and deposit (Note 18)

96,067

68,927
Total Current Assets

1,911,485

1,818,829

Capital assets, net

Patent (Note 9)

269,416

265,127
Property & Equipment (Note 10)

565,172

591,263

834,588

856,390
TOTAL ASSETS

$ 2,746,073

$ 2,675,219

LIABILITIES

Current

Accounts payable and accrued liabilities (Note 11)

$ 93,029

$ 136,411
Due to a related party (Note 15)

37,200

48,096
Total Current Liabilities

130,229

184,507
TOTAL LIABILITIES

130,229

184,507

STOCKHOLDERS' EQUITY

Share Capital (Note 12)

Authorized:

220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 80,610,879 common shares at November 30, 2019 and 78,787,134 common shares at August 31, 2019

80,611

78,787
Additional paid-in capital (Note 12, 13)

27,220,524

26,172,453
Deficit

(24,775,515 )

(23,868,202 )
Equity attributable to shareholders of the Company

2,525,620

2,383,038
Non-Controlling Interest

90,224

107,674
Total Stockholders' Equity

2,615,844

2,490,712
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$ 2,746,073

$ 2,675,219

The accompanying notes are an integral party of these consolidated financial statements.

Page 3 of 24

Table of Contents

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Expressed in U.S. Dollars, except number of shares)

	THREE MONTHS ENDED
	November 30			November 30
	2019			2018
	(Unaudited)			(Unaudited)
Revenue (Note 14)	$	62,082		$	22,209
Cost of Goods Sold		7,853			2,158
Gross profit		54,229			20,051

Expenses
Accounting and audit		19,036			9,572
Depreciation and Amortization (Note 8, 9, 10)		27,512			1,603
Advertising and promotions		46,268			171,913
Consulting (Notes 12, 13, 15)		483,796			242,991
Investor relations		17,515			-
Legal and professional		52,355			96,652
Office and miscellaneous		74,027			72,902
Research and development		107,463			96,973
Travel		21,853			19,206
Wages & Salaries		87,593			-
Unrealized Loss on marketable securities (Note 19)		41,574			9,630
		978,992			721,442

Net (loss) and comprehensive loss for the period	$	(924,763	)	$	(701,391	)
Net (loss) and comprehensive loss attributable to:
Common Shareholders	$	(907,313	)	$	(701,391	)
Non-Controlling Interest	$	(17,450	)	$	-

Basic and diluted (loss) per share	$	(0.01	)	$	(0.01	)

Weighted average number of common shares outstanding
-Basic and diluted		79,097,349			76,226,802

The accompanying notes are an integral party of these consolidated financial statements.

Page 4 of 24

Table of Contents

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED STATEMENT OF CASH FLOWS
(Expressed in U.S. Dollars)

THREE MONTHS ENDED

November 30

November 30

2019

2018

(Unaudited)

(Unaudited)

Cash flows used in operating activities

Net loss and comprehensive loss

$ (924,763 )

$ (701,391 )
Adjustments to reconcile net loss to net cash used in operating activities:

Consulting - Stock based compensation

162,414

64,044

Depreciation and amortization

27,512

1,603

Unrealized loss on marketable securities

41,574

9,630

Warrants issued for services

70,752

-

Change in working capital

Accounts receivable

57,269

(5,365 )
Inventory

(6,160 )

(29,435 )
Prepaid expenses and deposits

(27,140 )

10,302

Accounts payable and accrued liabilities

(43,382 )

72,499

Due to related parties

(10,896 )

13,799

Net cash used in operating activities

$ (652,820 )

$ (564,314 )

Cash flows used in investing activities

Patent

(5,710 )

(44,368 )
Property & Equipment

-

(122,832 )
Net cash used in investing activities

$ (5,710 )

$ (167,200 )

Cash flows from financing activities

Proceeds from issuance of equity

706,704

1,649,190

Net cash from financing activities

$ 706,704

$ 1,649,190

Decrease in cash and cash equivalents

48,174

917,676

Cash and cash equivalents, beginning of quarter

1,285,147

1,727,184

Cash and cash equivalents, end of quarter

$ 1,333,321

$ 2,644,860

Supplemental information of cash flows:

Income taxes paid in cash

$ 957

$ -
Subscription Receivable

$ 110,025

$ -

The accompanying notes are an integral part of these audited consolidated financial statements.

Page 5 of 24

Table of Contents

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Expressed in U.S. Dollars)

COMMON STOCK

SHARES

AMOUNT
$

ADDITIONAL
PAID-IN
CAPITAL $

DEFICIT
$

NCI
$

AOCI
$

STOCKHOLDERS’
EQUITY
$

Balance August 31, 2017

67,975761

67,976

16,108,270

(13,169,939 )

(238,476 )

-

2,767,831
Non-controlling interest

-

-

(318,820 )

-

248,820

-

(70,000 )
Shares issued for services

647,690

648

780,408

-

-

-

781,056

Stock based compensation

-

-

2,602,239

-

-

-

2,602,239

Warrants issued for services

-

-

1,063,270

-

-

-

1,063,270

Exercise of stock options

545,875

546

93,156

-

-

-

93,702

Exercise of warrants

6,364,145

6,363

1,767,159

-

-

-

1,773,522

Net loss

-

-

-

(6,598,843 )

(10,344 )

-

(6,609,187 )
Other comprehensive loss

-

-

-

-

-

(14,247 )

(14,247 )
Balance August 31, 2018

75,533,471

75,533

22,095,682

(19,768,782 )

-

(14,247 )

2,388,186
Shares issued for services

250,000

250

234,250

-

-

-

234,500

Stock based compensation

-

-

626,692

-

-

-

626,692

Warrants issued for services

-

-

52,817

-

-

-

52,817

Exercise of stock options

430,000

430

65,820

-

-

-

66,250

Exercise of warrants

1,626,513

1,627

794,496

-

-

-

796,123

Private Placement

947,150

947

1,469,363

-

-

-

1,470,310

Net loss

-

-

-

(4,099,420 )

-

-

(4,099,420 )
Non-controlling interest

-

-

-

-

(58,993 )

-

(58,993 )
Other comprehensive income

-

-

-

-

-

14,247

14,247

Subsidiary Investment

-

-

833,333

-

166,667

-

1,000,000

Balance August 31, 2019

78,787,134

78,787

26,172,453

(23,868,202 )

107,674

-

2,490,712
Stock based compensation

-

-

162,414

-

-

-

162,414

Warrants issued for services

-

-

70,752

-

-

-

70,752

Private Placement

1,579,245

1,579

705,125

-

-

-

706,704

Subscription Receivable

244,500

245

109,780

-

-

-

110,025

Net loss

-

-

-

(907,313
)

-

-

(907,313 )
Non-controlling interest

-

-

-

-

(17,450 )

-

(17,450 )
Balance November 30, 2019

80,610,879

80,611

27,220,524

(24,775,515 )

90,224

-

2,615,844

The accompanying notes are an integral part of these audited consolidated financial statements.

Page 6 of 24

Table of Contents

LEXARIA BIOSCIENCE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOVEMBER 30, 2019

(Expressed in U.S. Dollars)

1. Organization, Business and Going Concern

Lexaria Bioscience Corp. (“Lexaria”, or the “Company”) was formed on December 9, 2004 under the laws of the State of Nevada. In March of 2014, the Company began its entry into the bioscience and alternative health and wellness business and in May 2016, the Company commenced out-licensing its patented DehydraTECH™ technology (the “Technology”) for improved delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company has its office in Kelowna, BC, Canada.

The Company’s unaudited interim consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles (US GAAP) have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for a full year.

These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated annual financial statements and notes thereto included in our annual report filed on Form 10-K for the year ended August 31, 2019.

The Company’s unaudited interim consolidated financial statements have been prepared in accordance with US GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The recurring losses from operations and net capital deficiency raise substantial doubt about the Company’s ability to continue as a going concern.

The Company requires additional funds or revenues to maintain its operations and developments. Management’s plans in this regard are to raise equity and debt financing as required, but there is no certainty that such financing will be available or that it will be available at acceptable terms. The outcome of these matters cannot be predicted at this time.

2. Business Risk and Liquidity

The Company is subject to several categories of risk associated with its operating activities. The production and sale of alternative health products is an emerging industry in which business practices are not yet standardized and are subject to frequent scrutiny and evaluation by federal, state, provincial, and municipal authorities, academics, and media outlets, among others. Although we intend to develop our businesses in accordance with best ethical practices, we may suffer negative publicity if we, our partners, contractors, or customers are found to have engaged in any environmentally insensitive practices or other business practices that are viewed as unethical.

Our operations may require licenses and permits from various governmental authorities. We believe that we will be able to obtain all necessary licenses and permits under applicable laws and regulations for our operations and believe we will be able to comply in all material respects with the terms of such licenses and permits. However, such licenses and permits are subject to change in various circumstances. There can be no guarantee that we will be able to obtain or maintain all necessary licenses and permits, and failing to obtain or retain required licenses could have a materially adverse effect on the Company.

Lexaria and its subsidiaries are not involved directly or indirectly in the cultivation, processing, distribution, or utilization of cannabis or cannabis derived components. All of Lexaria’s consumer products utilize legally sourced hemp and hemp components in their production. Lexaria does have an ancillary involvement risk via out-licensing of its patented technology to licensees that choose to utilize its Technology to manufacture products that contain locally or state approved but federally regulated and controlled contents. There can be no guarantee that changes in the regulatory framework and environment will not occur and such changes could have a materially adverse effect on the Company.

Page 7 of 24

Table of Contents

Lexaria and its subsidiaries are not involved directly or indirectly in the production or sale of any products containing nicotine. Products containing nicotine have historically been involved in litigation in the USA. Lexaria’s corporate licensee may introduce products containing nicotine that utilize Lexaria’s Technology to the US consumer market, which could therefore introduce third-party risks to Lexaria.

3. Significant Accounting Policies

The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.

4. Basis of Consolidation

These consolidated financial statements include the financial statements of the Company and its wholly owned subsidiaries; Lexaria CanPharm ULC, PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp. and Lexaria Pharmaceutical Corp., and our 83.333% subsidiary Lexaria Nicotine LLC (16.667% Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc.). All significant intercompany balances and transactions have been eliminated.

5. Estimates and Judgments

The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company’s accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.

The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.

In preparing these unaudited interim consolidated financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended August 31, 2019.

6. Recent Accounting Guidance

In February 2016 FASB issued ASU No. 201602, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and the lessors. The new standard requires the lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right of use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2020. When adopted, the Company does not expect this guidance to have a material impact on its consolidated financial statements.

Page 8 of 24
Table of Contents

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available for sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2022. Application of the amendments is through a cumulative effect adjustment to deficit as of the effective date. The Company is currently assessing the impact of the standard on its consolidated financial statements.

In February 2018, the FASB issued ASU No. 201802, Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted by the U.S. federal government on December 22, 2017 (the “2017 Tax Act”). Consequently, the amendments eliminate the stranded tax effects resulting from the 2017 Tax Act and will improve the usefulness of information reported to financial statement users. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

In June 2018, the FASB issued ASU No. 201807, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share Based Payment Accounting. This is a simplification that involves several aspects of accounting for nonemployee share-based payments resulting from expanding the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

7. Accounts and Other Receivables

November 30

August 31

2019

2019

$

$

Trade and deposits receivable

5,458

5,727

Territory license fee receivable

124,324

106,000

Sales tax receivable

86,094

161,418

Subscription receivable

110,025

-

325,901

273,145

8. Inventory

November 30

August 31

2019

2019

$

$

Raw materials

58,806

45,068

Finished goods

74,750

82,328

133,556

127,396

During the period ended November 30, 2019, the Company wrote down $NIL (2019 - $7,182) of inventory to reflect its net realisable value.

9. Intellectual Property

The following is a list of US capitalized patents held by the Company

Issued Patent #	Patent Issuance Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	05/15/2018
US 9,974,739 B2	05/22/2018
US 10,084,044 B2	09/25/2018
US 10,103,225 B2	10/16/2018
US 10,381,440	08/13/2019
US 10,374,036	08/06/2019

Page 9 of 24

Table of Contents

The Company also holds non-capitalized patents outside the US. A continuity schedule for capitalized patents is presented below:

November 30

August 31

2019

2019

$

$

Balance – beginning

265,127

146,538

Addition

5,710

122,982

Amortization*

(1,421 )

(4,393 )
Balance – ending

269,416

265,127

*The patents are amortized over their legal life of 20 years.

10. Property & Equipment

Net Balance

Year Ended August 31, 2019

Cost

Period
Amortization

Accumulated
Amortization

August 31,
2019

$

$

$

$

Leasehold improvements

259,981

(33,342 )

(33,342 )

226,639

Computers

63,964

(12,187 )

(12,187 )

51,777

Furniture fixtures equipment

34,220

(4,205 )

(6,062 )

28,158

Lab equipment

291,235

(6,546 )

(6,546 )

284,689

649,400

(56,281 )

(58,137 )

591,263

									Net Balance
Quarter Ended November 30, 2019	Cost		Amortization Period			Accumulated Amortization			November 30, 2019
	$		$			$			$
Leasehold improvements		259,981		(12,740	)		(46,082	)		213,899
Computers		63,964		(4,920	)		(17,107	)		46,857
Furniture fixtures equipment		34,220		(1,759	)		(7,821	)		26,399
Lab equipment		291,235		(6,672	)		(13,218	)		278,017
		649,400		(26,091	)		(84,228	)		565,172

11. Accounts Payable and Accrued Liabilities

November 30

August 31

2019

2019

$

$

Accounts Payable

Trades payable

89,254

31,463

Sales tax payable

-

63,616

Accrued Liabilities

Trades payable

3,775

41,332

Balance – Ending

93,029

136,411

12. Common Shares and Warrants

Fiscal 2020 Activity

During the period ended November 30, 2019 the Company closed, pursuant to two tranches, a non-brokered private placement for an aggregate total of 1,823,745 Units priced at $0.45 each. Each Unit consists of one common share and one Share purchase warrant. Each warrant shall entitle the holder to acquire one common share of the Company for a period of two years at a price of $0.80 per Share until the first anniversary of issuance for a period of 12 months, and thereafter at a price of $1.20 for an additional 12 months until November 13, 2021 until the second anniversary of issuance. The Company paid $3,937.50 and issued 8,750 broker warrants. The broker warrants have a term of 24 months and are each exercisable into one common share of the Company at a price of $0.80 per Share until the first anniversary of issuance, and thereafter at a price of $1.20 until the second anniversary of issuance. The fair value of these broker warrants was determined to be $1,850, which were recorded as a share issuance cost within additional paid in capital for a net effect of $Nil.

Page 10 of 24

Table of Contents

During the period ended November 30, 2019 the Company recognized $70,752 in consulting expense for warrants granted to a consultant on vesting.

A summary of share issuance relating to option and warrant exercises, agreement requirements and debt settlement is presented below:

Type of Issuance

Number of
Shares

Total
Value

Private placement

1,823,745

$ 820,685

1,823,745

$ 820,685

A continuity schedule for warrants is presented below:

	Number of Warrants			Weighted Average Exercise Price $
Balance August 31, 2018		3,286,274			0.72
Cancelled/Expired		(17,498	)		0.59
Exercised		(1,626,513	)		0.49
Issued		1,183,062			1.99
Balance August 31, 2019		2,825,325			1.38
Issued		2,057,495			0.80
Balance November 30, 2019		4,882,820			1.14

The fair value of share purchase warrants granted as broker warrants, compensation units, and compensatory warrants, was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

	November 30 2019
Expected volatility		91	%
Risk-free interest rate		2.87	%
Expected life		2 years
Dividend yield		0.00	%
Estimated fair value per warrant	$	0.28-$0.43

A summary of warrants outstanding as of November 30, 2019 is presented below:

# of Warrants	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price $
250,000	0.01 years	0.83
500,000	0.13 years	1.83
975,325	0.92 years	2.25
100,000	1.48 years	0.96
250,000	1.48 years	1.55
750,000	1.86 years	0.14
225,000	2.00 years	0.80
1,832,495	2.00 years	0.80
4,882,820	1.46 years	1.14

Page 11 of 24

Table of Contents

13. Stock Options

The Company has established its 2007 Equity Incentive Plan, whereby the board of directors may grant up to 412,500 stock options to eligible employees and directors, the 2010 Stock Option Plan whereby the board of directors may, from time to time, grant up to 1,512,500 stock options to officers and employees; the 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 2,107,500 stock options to directors, officers, employees, and consultants; and the 2019 Equity Incentive Plan whereby the board of directors may, from time to time, grant up to 7,838,713 stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors.

Fiscal 2020 Activity

The Company granted in the period ending November 30, 2019:

Quantity	Exercise Price $	Life (Years)
500,000⁽¹⁾	0.55	5
500,000⁽²⁾	0.55	5
1,000,000	0.55

__________

⁽¹⁾Options granted vest 50,000 on grant and the remainder based on contracted milestones

⁽²⁾Options granted vest 250,000 on grant and the remainder based on contracted milestones

A continuity schedule for stock options is presented below:

Options

Weighted

Average

Exercise Price

Weighted

Average

Remaining Contractual

Term (Years)

Aggregate

Intrinsic Value

Balance August 31, 2018

4,800,000

0.71

Expired/cancelled

(1,415,000

)

0.66

Exercised

(430,000

)

0.15

Granted

2,048,000

1.00

Balance August 31, 2019

5,003,000

0.89

Granted

1,000,000

0.55

Balance November 30, 2019 (Outstanding)

6,003,000

0.84

3.41

931,800

Balance November 30, 2019 (Exercisable)

4,261,341

0.88

2.94

794,300

The fair value of options granted was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

	November 30 2019
Expected volatility		96	%
Risk-free interest rate		1.66	%
Expected life		5 years
Dividend yield		0.00	%
Estimated fair value per option	$	0.39

Page 12 of 24

Table of Contents

14. Revenues

	November 30 2019 $		November 30 2018 $
Product sales		10,015		2,257
Licensing revenue		51,750		19,902
Freight revenue		317		50
		62,082		22,209

During the period ended November 30, 2019, the Company recognized $37,750 of Intellectual Property Licensing fees and $18,000 of Usage Fees (November 2018 - $Nil and $19,902). Licensing revenues are significantly concentrated on a single customer.

There was an increase in product sales in the current year compared to the previous years as the Company was able to solve some payment processing issues late in fiscal 2019, allowing for improved ability to conduct retail transactions. The Licensing fees consist of IP licensing fees for transfer of the Technology with the signing of definitive agreements for the DehydraTECH technology and usage fees. The Licensing fees include payments due upon transfer of the Technology and installment payments that are receivable within 12 months (Note 7).

15. Related Party Transactions

	Nov 30 2019 Total $		Nov 30 2018 Total $
Management, consulting and accounting services
C.A.B Financial Services⁽¹⁾		65,757		36,000
M&E Services Ltd.⁽¹⁾		29,382		27,422
Docherty Management Limited⁽¹⁾		56,730		34,278
Directors		16,717		-
		168,586		97,700

⁽¹⁾ C.A.B. Financial Services is owned by the CEO of the Company, M&E Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.

Due to related parties:

As at November 30, 2019, $37,200 (August 31, 2019 - $48,096) was payable to related parties included in due to related parties.

The related party transactions are recorded at the exchange amount established and agreed to between the related parties.

16. Segment Information

The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on one licensee.

Page 13 of 24

Table of Contents

IP Licensing

Consumer
Products

Corporate

Consolidated
Total

External revenue

$ 51,750

$ 10,332

$ -

$ 62,082

CoGS

$ -

$ (7,853 )

$ -

$ (7,853 )
Operating expenses

$ (104,678 )

$ (42,020 )

$ (832,294 )

$ (978,992 )
Segment loss

$ (52,928 )

$ (39,541 )

$ (832,294 )

$ (924,763 )
Total assets

$ 678,429

$ 133,556

$ 1,934,088

$ 2,746,073

17. Commitments, Significant Contracts and Contingencies

Management and Service Agreements:

As at November 30, 2019, the Company is party to the following contractual commitments:

Party	Monthly Commitment	Expiry Date
C.A.B Financial Services	CAD $29,167	January 1, 2022
Docherty Management Ltd.	CAD $25,000	January 1, 2022
M&E Services Ltd.	CAD $12,960	June 1, 2021
Corporate development	CAD $1,000	Month to Month
Corporate development	CAD $8,000	Month to Month
Investor relations and communications – Alex Blanchard Capital	CAD $7,500	Month to Month
Office management	CAD $10,000	August 15, 2022
Research & development	CAD $3,854	Month to Month
Office rent⁽¹⁾	CAD $4,823	November 15, 2023

Corporate Offices:

(1) Corporate office and R&D lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.

18. Prepaid Expenses

Prepaid expenses consist of the following at November 30, 2019 and August 31, 2019:

	November 30 2019 $		August 31 2019 $
Advertising & Conferences		54,587		39,143
Office & Insurance		41,480		29784
		96,067		68,927

19. Marketable Securities

The components of Marketable Securities were as follows:

Cost Basis

Unrealized

Gains

Unrealized

Losses

Total

August 31, 2019

Common stock

81,250

9,335

(12,124

)

Total

81,250

9,335

(26,973

)

63,612

November 30, 2019

Common stock

81,250

9,335

(40,972

)

Total

81,250

9,335

(67,945

)

22,640

Unrealized losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence.

20. Subsequent Events

a) Subsequent to November 30, 2019, 110,000 options were exercised for a total of $11,000.

Page 14 of 24

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Statements

This quarterly report contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact may be forward-looking statements. These statements relate to future events or our future financial performance. Any forward-looking statements are based on our present beliefs and assumptions as well as the information currently available to us. In some cases, you can identify forward-looking statements by terminology such as "may", “will”, "should", “could”, “targets”, “goal”, "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors" set forth in Item 1(A) in our annual report on Form 10-K, as filed with the Securities and Exchange Commission on November 14, 2019, that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We caution you not to place undue reliance on any forward-looking statements as they speak only as of the date on which such statements were made, and we undertake no obligation to update any forward-looking statement or to reflect the occurrence of an unanticipated event. New factors may emerge and it is not possible to predict all factors that may affect our business and prospects. Further, management cannot assess the impact of each factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Our unaudited interim consolidated financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP). The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars. All references to "C$" or "CDN$" refer to Canadian dollars and all references to "common shares" and "shares" refer to the common shares in our capital stock, unless otherwise indicated. The terms "Lexaria" "we", "us", "our" and "Company" mean Company and/or our subsidiaries, unless otherwise indicated.

Company and Business Overview

We are a bioscience intellectual property (IP) research, development and licensing company for our patented lipid nutrient infusion DehydraTECH™ technology (the “Technology”) and were incorporated in 2004 in Nevada. Our Technology improves delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery.

The Company’s food sciences activities include the development of our proprietary nutrient infusion technologies for the production of functional foods, and the production of enhanced food products under our consumer product brands, ViPova™, Lexaria Energy™, TurboCBD™ and ChrgD+™. The Company’s Technology is believed to improve taste, rapidity and delivery of bioactive compounds that include cannabinoids, vitamins, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), nicotine and other molecules compared to what is possible without lipophilic enhancement technology. All of Lexaria’s consumer product goods are made with commonly available food grade ingredients and are sold through e-commerce platforms and fulfillment centers.

Lexaria hopes to reduce other common, but less healthy administration methods such as smoking, as industry segments embrace the benefits of our technology for public health. The Company is aggressively pursuing patent protection in national jurisdictions around the world and has more than 50 patent applications pending worldwide. Due to the complexity of pursuing patent protection, the quantity of patent applications will vary continuously as each application advances or stalls. Lexaria is also filing new patent applications for novel new discoveries that arise from the Company’s R&D programs and, due to the inherent unpredictability of scientific discovery, it is not possible to predict if or how often such new applications might be filed.

As at November 30, 2019, we have identified two reportable operating segments: Intellectual Property Licensing and Consumer Products.

Page 15 of 24

Table of Contents

Our Current Business

Our Company’s business plan is currently focused on the development of strategic partnerships with licensees for our patented Technology in exchange for up front and/or staged licensing fees over time. Secondarily and more generally, we continue to investigate national and international opportunities for development and distribution of the Company’s enhanced functional food and supplement product offerings; to investigate expansions and additions to our intellectual property portfolio; and to search for additional opportunities in alternative health sectors. This includes the acquisition or development of intellectual property if and when we believe it is advisable to do so.

Our current patent portfolio includes patent family grants relating to: Infused Food and Beverage Compositions and Methods of Use Thereof, pertaining to Lexaria’s method of improving bioavailability and taste, and the use of the Technology as a delivery platform for a wide variety of Active Pharmaceutical Ingredients (“APIs”) encompassing all cannabinoids including CBD and THC, fat soluble vitamins, non-steroidal anti-inflammatory pain medications (“NSAIDs”); and nicotine.

To date, the following patents have been awarded:

Issued Patent #	Patent Issuance Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	5/15/2018
US 9,974,739 B2	5/22/2018
US 10,084,044 B2	9/25/2018
US 10,103,225 B2	10/16/2017
US 10,381,440	8/13/19
US 10,374,036	8/06/19
AUS 2015274698	6/15/2017
AUS 2017203054	8/30/2018
AUS 2018202562	8/30/2018
AUS 2018202583	8/30/2018
AUS 2018202584	1/10/2019
AUS 2018220067	7/30/2019
AUS 2016367036	7/30/2019	Methods for Formulating Orally Ingestible Compositions Comprising Lipophilic Active Agents
AUS 2016367037	8/15/2019	Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents

We are seeking additional patent protection for what we believe to be a unique process for the nutritional delivery of certain molecules such as Cannabinoids, Nicotine, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Vitamins. To achieve sustainable and profitable growth, our Company intends to control the timing and costs of our projects wherever possible. We have filed for patent protection of our Technology for additional compounds such as phosphodiesterase inhibitors, human hormones such as estrogen and testosterone and more.

During the period ended November 30, 2019, and up to the date of this report, we experienced the following significant corporate developments:

The Company closed a non-brokered private placement of unregistered securities for a total of 1,823,745 Units priced at $0.45 each. Each Unit consists of one common share and one share purchase warrant. Each warrant shall entitle the holder to acquire one common share of the Company for a period of two years at a price of $0.80 per Share until the first anniversary of issuance, and thereafter at a price of $1.20 until the second anniversary of issuance. The Company paid $3,937.50 and issued 8,750 broker warrants. The broker warrants have a term of 24 months and are each exercisable into one common share of the Company at a price of $0.80 per Share until the first anniversary of issuance, and thereafter at a price of $1.20 until the second anniversary of issuance. The fair value of these broker warrants was determined to be $1,850, which were recorded as a share issuance cost within additional paid in capital for a net effect of $Nil.

The Units were issued pursuant to registration exemptions either by way of the investor being an accredited investor as evidenced by the completion of an accredited investor certification, pursuant to Regulation D, Rule 506 (b), or a person representing that he is not a US person or acting on behalf of a US Person, pursuant to Regulation S, Rule 903, who purchased the securities in an offshore transaction and will bear the required regulatory hold period legends.

Subsequent to November 30, 2019, 110,000 options were exercised for a total of $11,000.

Page 16 of 24

Table of Contents

Research and Development

Lexaria incurred $107,463 (2018 $96,973) in research and development expenditures during the period ending November 30, 2019. Specific R&D programs are in ongoing development and will be tightly related to our financial ability to undertake each research phase for each API. Due to our expanding portfolio coverage, we are continuing to examine accelerated timetable options for testing, research and development of each API.

The Company’s plans to include in vitro absorption tests of our patented technology of molecules such as: Vitamin E, Ibuprofen, and Nicotine allowed us to perform testing on Nicotine with positive results. Our plan to conduct our first ever in vivo absorption tests on CBD also yielded positive results. Ongoing testing plans are proceeding to further define molecular compatibility, absorption rates, timing and viable formats of delivery.

The Company continually focuses on new R&D programs to investigate the potential of additional commercial applications for its technology. These include, but are not limited to ongoing programs to explore methods to integrate nanoemulsification chemistry techniques together with its technology and to further enhance intestinal bioabsorption rates with its technology, as well as ongoing programs to expand the types and breadth of product form factors into which its technology can be applied. Depending on how many of these tests are undertaken, R&D budgets are expected to vary significantly. It is in our best interests to remain flexible at this early stage of our R&D efforts in order to capitalize on potential novel findings from early-stage tests and thus re-direct research into specific avenues that offer the most reward.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Critical Accounting Estimates

Our consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles used in the United States (US GAAP). Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management's application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financials.

Capital Assets

Capital assets are stated at cost less accumulated depreciation and depreciated using the straight-line method over their useful lives or by units of production.

Patents

Capitalized patent costs represent legal costs incurred to establish patents. When patents reach a mature stage, any associated legal costs are comprised mostly of maintenance fees and are expensed as incurred. Capitalized patent costs are amortized on a straight-line basis over the remaining life of the patent.

Revenue Recognition

Product Revenue

Revenue from the sale of alternative health products is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured, which typically occurs upon shipment. The Company reports its sales net of the amount of actual sales returns. Sales tax collected from customers is excluded from net sales.

Page 17 of 24

Table of Contents

Licensing Revenue from Intellectual Property

We recognize revenue for license fees at a point in time following the transfer of our intellectual property, our patented lipid nutrient infusion technology DehydraTECH for infusing APIs, to the licensee, which typically occurs on delivery of documentation.

Usage Fees from Intellectual Property

We recognize revenue for usage fees when usage of our DehydraTECH intellectual property occurs by licensees infusing an API into one or more of their product lines for sale.

Going Concern

We have suffered recurring losses from operations. The continuation of our Company as a going concern is dependent upon our Company attaining and maintaining profitable operations and/or raising additional capital. The financial statements do not include any adjustment relating to the recovery and classification of recorded asset amounts or the amount and classification of liabilities that might be necessary should our Company discontinue operations. The recurring losses from operations and net capital deficiency raise substantial doubt about the Company’s ability to continue as a going concern.

Results of Operations for our Period Ended November 30, 2019 and November 30, 2018

Our net loss and comprehensive loss and the changes between those periods for the respective items are summarized as follows:

PERIOD ENDED

PERIOD ENDED

November 30

November 30

2019

2018

Change

Revenue

$ 62,082

$ 22,209

$ 39,873

General and administrative

978,992

721,442

257,550

Consulting fees & Employees

571,389

242,991

328,398

Legal and professional

52,355

96,652

(44,297 )
Net Loss

$ (924,763 )

$ (701,391 )

$ (223,372 )

Revenue

Licensing revenues of $51,750 represent the majority of revenues during the period ended November 30, 2019 and reflect delays in usage fee revenues from existing licensees in Canada waiting for product approval from Health Canada on products, and other licensees initiating or ramping up their production. Licensing revenue was primarily based on expanded licence agreements entered into recognising the IP Territory Licensing fee, and existing licenses generating usage fees. Increasing ongoing usage fees are expected as licensees begin or ramp up products or when contracted minimum requirements become due.

Increases in revenues are expected during the 2020 calendar year.

Our licensing revenues consist of IP licensing fees for the transfer of the Technology at the signing of definitive agreements for the Technology. The additional licensing fees include payments due upon transfer of the Technology and installment payments that are receivable within 12 months (Note 7).

During the period ended November 30, 2019, our revenues were derived within the following categories: $51,750 (November 2018 $19,902) of intellectual property licensing revenue and $10,332 (2018 $2,307) in product and other revenues.

Page 18 of 24

Table of Contents

General and Administrative

Our general and administrative expenses increased by $223,372 during the period ended November 30, 2019. The increase was primarily due to non-cash expenses related to valuation of grants for service and share-based payments required by contracts totaling $233,166, but also reflect contracts entered into during fiscal 2019. Increases included the new staff members as of January 2019, amortization of equipment and unrealized losses on marketable securities. Offsetting reductions included reduced advertising and patent filing costs.

Interest Expense

Interest expense for the period ended November 30, 2019 was $Nil (2018 $Nil). The Company has no debt at this time other than month-to-month receivables.

Consulting fees

Our consulting fees increased by $242,991, almost entirely due to the non-cash share-based payments for services of $233,166 but also reflect the contracts entered into with officers in fiscal 2019 and business development contracts.

Legal and Professional Fees

Our professional fees decreased by $44,297 during the period primarily due to reduced patent and trademark filings, and fewer other advisory services utilized during the period. We recognize certain legal fees, tax advice fees, and accounting services all as “Professional Fees.”

Liquidity and Financial Condition

Working Capital

November 30
2019

August 31
2019

Current assets

$ 1,911,485

$ 1,818,829

Current liabilities

$ (130,229 )

$ (184,507 )
Net Working Capital

$ 1,781,256

$ 1,634,322

The Company’s working capital balance decrease during the year was limited due to exercises of outstanding options and warrants and the private placement (Note 12) completed during the year. The Company maintained a positive and relatively strong working capital position throughout the period.

November 30

November 30

Cash Flows

2019

2018

Cash flows (used in) provided by operating activities

$ (762,845 )

$ (564,314 )
Cash flows (used in) provided by investing activities

$ (5,710 )

$ (167,200 )
Cash flows provided by financing activities

$ 816,729

$ 1,649,190

Decrease in cash

$ 48,174

$ 917,676

Operating Activities

Net cash used in operating activities was $762,845 for the period compared with cash used in operating activities of $564,314 during the same period in 2018. This difference was largely due to the increased costs pertaining to consulting and staff wages.

Page 19 of 24

Table of Contents

Investing Activities

Net cash used in investing activities was $5,710 (2018 $167,200) for the period due to the Company having incurred significant capital asset acquisition costs during fiscal 2019 and the patent and trademark filings in period relating to maintaining our portfolio.

Financing Activities

Net cash provided from financing activities was $706,704 during the period ended November 30, 2019 compared to net cash provided of $1,649,190 during the same period in 2018.

Liquidity and Capital Resources

We have accumulated a large deficit since inception that has primarily resulted from executing our business plan including research and development expenditures we have made in seeking to identify and develop our intellectual property patents for licensing and product creation. We expect to continue to incur losses for at least the short term.

To date, we have obtained cash and funded our operations primarily through equity financings and limited amounts from revenue generation while our licensees ramp up production and expansions. We expect to continue to evaluate various funding alternatives on an ongoing basis as needed to maintain operations, to continue our research programs and to expand our patent portfolio. If we determine it is advisable to raise additional funds, there is no assurance that adequate funding will be available to us or, if available, that such funding will be available on terms that we or our stockholders view as favorable.

Short Term Liquidity

At November 30, 2019 we had $1.3 million in cash and cash equivalents. We believe our cash resources are sufficient to allow us to continue operations for at least the next six months from the date of this Quarterly Report.

Long Term Liquidity

It will require substantial cash to achieve our objectives for developing and patenting our intellectual property across all applicable market and industry segments. This process typically takes many years and potentially millions of dollars for each segment. We will need to obtain significant funding from existing or new relationships, such as our research program with the Altria Group, increasing revenue streams or from other sources of liquidity such as the sale of equity, issuance of debt or other transactions.

The exact requirements will vary depending on the results of research programs and the requirements of each industry segment that we pursue. Pursuit of each segment will be prosecuted or curtailed based on available sources of cash with which to execute individual segment business plans. The requirements will also be affected by transactions with existing or new relationships and the depth of regulatory requirements in each segment for compliance required to approve our IP, to market and license it. These changes to requirements and transactions may impact our liquidity as well as affect our expenses if, for example, regulatory requirements necessitated additional testing incurring additional research time and costs and potentially delaying licensing our IP for a segment.

Item 3. Controls and Procedures

Management’s Report on Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our President and Chief Executive Officer (also our Principal Executive Officer) and our Chief Financial Officer (also our Principal Financial and Accounting Officer) to allow for timely decisions regarding required disclosure.

Page 20 of 24

Table of Contents

As of November 30, 2019, the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our President and CEO and CFO (also our Principal Executive and Financial Reporting and Accounting Officers), of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our President, CEO and the CFO concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of November 30, 2019.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of control procedures. The objectives of internal control include providing management with reasonable, but not absolute, assurance that assets are safeguarded against loss from unauthorized use or disposition, and that transactions are executed in accordance with management’s authorization and recorded properly to permit the preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States. Our management assessed the effectiveness of our internal control over financial reporting as of November 30, 2019. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. Our management has concluded that, as of November 30, 2019, our internal control over financial reporting is effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with US GAAP. Our management reviewed the results of their assessment with our Board of Directors.

Inherent limitations on Effectiveness of Controls

Internal control over financial reporting has inherent limitations which include but is not limited to the use of independent professionals for advice and guidance, interpretation of existing and/or changing rules and principles, segregation of management duties, scale of organization, and personnel factors. Internal control over financial reporting is a process which involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a timely basis, however these inherent limitations are known features of the financial reporting process and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

During the quarter ended November 30, 2019 our controls and controls processes remained consistent with August 31, 2019. There have been no changes in our internal controls over financial reporting that occurred during the quarter ended November 30, 2019 that have materially or are reasonably likely to materially affect, our internal controls over financial reporting.

Page 21 of 24

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

We know of no other material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any other material proceeding or pending litigation. There are no other proceedings in which any of our directors, executive officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest.

Item 1A. Risk Factors

Much of the information included in this quarterly report includes or is based upon estimates, projections or other "forward looking statements". Such forward looking statements include any projections or estimates made by us and our management in connection with our business operations. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein.

The risks associated with our business, common stock and other factors were the same as those described in the consolidated financial statements for the year ended August 31, 2019.

Page 22 of 24

Table of Contents

PART IV

Item 15. Exhibits, Financial Statement Schedules

a)
Financial Statements

1) Financial statements for our Company are listed in the index under Item 8 of this document

2) All financial statement schedules are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto.

b)
Exhibits

Exhibit Number		Description
(3)*		Articles of Incorporation and Bylaws
3.1*		Articles of Incorporation
3.2*		Bylaws

(21)		Subsidiaries
21.1		Lexaria Canpharm ULC, a British Columbia Canada corporation
21.2		Poviva Corp, a Nevada corporation
21.3		Lexaria Hemp Corp., a Delaware corporation
21.4		Lexaria Nicotine LLC, a Delaware corporation
21.5		Lexaria Canpharm Holding Corp., a Nevada corporation
21.6		Lexaria Pharma Corp., a Delaware corporation

(31)		Rule 13(a) - 14 (a)/15(d) - 14(a)
31.1*		Section 302 Certifications under Sarbanes-Oxley Act of 2002 of Principal Executive Officer
31.2*		Section 302 Certifications under Sarbanes-Oxley Act of 2002 of Principal Financial Officer and Principal Accounting Officer
(32)		Section 1350 Certifications
32.1		Section 906 Certification under Sarbanes Oxley Act of 2002 of Principal Executive Officer
32.2		Section 906 Certification under Sarbanes Oxley Act of 2002 of Principal Financial Officer and Principal Accounting Officer

(101)**		Interactive Data Files
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

____________

*Incorporated by reference to same exhibit filed with the Company's Registration Statement on Form SB-2 dated January 10, 2006.

** Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of any registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

Page 23 of 24

Table of Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LEXARIA BIOSCIENCE CORP.

By: /s/ Christopher Bunka
Christopher Bunka

Chief Executive Officer, Chairman and Director
(Principal Executive Officer)
Date:
January 8, 2020

In accordance with the Exchange Act, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:
/s/ Christopher Bunka

Christopher Bunka

Chief Executive Officer, Chairman and Director

(Principal Executive Officer)

Date:
January 8, 2020

By:
/s/ John Docherty

John Docherty

President and Director

Date:
January 8, 2020

By:
/s/ Allan Spissinger

Allan Spissinger CPA, CA

Chief Financial Officer

(Principal Financial Officer)

Date:
January 8, 2020

Page 24 of 24

EX-31.1 2 lxrp_ex311.htm CERTIFICATION lxrp_ex311.htm

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Chris Bunka, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Lexaria Bioscience Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's first fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 8, 2020

/s/ " Chris Bunka "
Chris Bunka
CEO and Director
(Principal Executive Officer)

EX-31.2 3 lxrp_ex312.htm CERTIFICATION lxrp_ex312.htm

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Allan Spissinger, certify that:

Date: January 8, 2020

/s/ "Allan Spissinger"
Allan Spissinger CPA, CA
Chief Financial Officer and Treasurer
(Principal Financial Officer and Principal Accounting Officer)

EX-32.1 4 lxrp_ex321.htm CERTIFICATION lxrp_ex321.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Chris Bunka, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q of Lexaria Bioscience Corp. for the quarter ended November 30, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lexaria Bioscience Corp.

Dated: January 8, 2020


		/s/ " Chris Bunka "
		Chris Bunka
		CEO and Director
		(Principal Executive Officer)
		Lexaria Bioscience Corp.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Lexaria Bioscience Corp. and will be retained by Lexaria Bioscience Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 lxrp_ex322.htm CERTIFICATION lxrp_ex322.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Allan Spissinger, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

Dated: January 8, 2020


		/s/ " Allan Spissinger "
		Allan Spissinger CPA, CA
		Chief Financial Officer and Treasurer
		(Principal Financial Officer and Principal Accounting Officer)
		Lexaria Bioscience Corp.

EX-101.INS 6 lxrp-20191130.xml XBRL INSTANCE DOCUMENT 0001348362 2018-10-01 2018-10-31 0001348362 2017-08-31 0001348362 us-gaap:AdditionalPaidInCapitalMember 2017-08-31 0001348362 us-gaap:CommonStockMember 2017-08-31 0001348362 us-gaap:NoncontrollingInterestMember 2017-08-31 0001348362 us-gaap:RetainedEarningsMember 2017-08-31 0001348362 2017-09-01 2018-08-31 0001348362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-01 2018-08-31 0001348362 us-gaap:AdditionalPaidInCapitalMember 2017-09-01 2018-08-31 0001348362 us-gaap:CommonStockMember 2017-09-01 2018-08-31 0001348362 us-gaap:NoncontrollingInterestMember 2017-09-01 2018-08-31 0001348362 us-gaap:RetainedEarningsMember 2017-09-01 2018-08-31 0001348362 2018-08-31 0001348362 lxrp:Fiscal2020ActivityMember 2018-08-31 0001348362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-08-31 0001348362 us-gaap:AdditionalPaidInCapitalMember 2018-08-31 0001348362 us-gaap:CommonStockMember 2018-08-31 0001348362 us-gaap:RetainedEarningsMember 2018-08-31 0001348362 2018-09-01 2018-11-30 0001348362 lxrp:FreightrevenueMember 2018-09-01 2018-11-30 0001348362 lxrp:IntellectualPropertyLicensingFeesMember 2018-09-01 2018-11-30 0001348362 lxrp:UsageFeesMember 2018-09-01 2018-11-30 0001348362 us-gaap:LicenseMember 2018-09-01 2018-11-30 0001348362 us-gaap:ProductMember 2018-09-01 2018-11-30 0001348362 lxrp:BoardOfDirectorFeesMember 2018-09-01 2018-11-30 0001348362 lxrp:CABFinancialServicesMember 2018-09-01 2018-11-30 0001348362 lxrp:DochertyManagementLimitedMember 2018-09-01 2018-11-30 0001348362 lxrp:MEServicesLtdMember 2018-09-01 2018-11-30 0001348362 2018-09-01 2019-08-31 0001348362 lxrp:Fiscal2020ActivityMember 2018-09-01 2019-08-31 0001348362 us-gaap:CommonStockMember 2018-09-01 2019-08-31 0001348362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-01 2019-08-31 0001348362 us-gaap:AdditionalPaidInCapitalMember 2018-09-01 2019-08-31 0001348362 us-gaap:CommonStockMember 2018-09-01 2019-08-31 0001348362 us-gaap:NoncontrollingInterestMember 2018-09-01 2019-08-31 0001348362 us-gaap:RetainedEarningsMember 2018-09-01 2019-08-31 0001348362 2018-11-30 0001348362 2019-08-31 0001348362 lxrp:Fiscal2020ActivityMember 2019-08-31 0001348362 lxrp:PeriodAmortizationMember 2019-08-31 0001348362 us-gaap:AccountsPayableMember 2019-08-31 0001348362 us-gaap:AccruedLiabilitiesMember 2019-08-31 0001348362 us-gaap:CommonStockMember 2019-08-31 0001348362 lxrp:LabEquipmentMember 2019-08-31 0001348362 lxrp:PeriodAmortizationMember lxrp:LabEquipmentMember 2019-08-31 0001348362 us-gaap:ComputerEquipmentMember 2019-08-31 0001348362 lxrp:PeriodAmortizationMember us-gaap:ComputerEquipmentMember 2019-08-31 0001348362 us-gaap:FurnitureAndFixturesMember 2019-08-31 0001348362 lxrp:PeriodAmortizationMember us-gaap:FurnitureAndFixturesMember 2019-08-31 0001348362 us-gaap:LeaseholdImprovementsMember 2019-08-31 0001348362 lxrp:PeriodAmortizationMember us-gaap:LeaseholdImprovementsMember 2019-08-31 0001348362 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0001348362 us-gaap:CommonStockMember 2019-08-31 0001348362 us-gaap:NoncontrollingInterestMember 2019-08-31 0001348362 us-gaap:RetainedEarningsMember 2019-08-31 0001348362 2019-09-01 2019-11-30 0001348362 lxrp:FreightrevenueMember 2019-09-01 2019-11-30 0001348362 lxrp:IntellectualPropertyLicensingFeesMember 2019-09-01 2019-11-30 0001348362 lxrp:UsageFeesMember 2019-09-01 2019-11-30 0001348362 us-gaap:LicenseMember 2019-09-01 2019-11-30 0001348362 us-gaap:ProductMember 2019-09-01 2019-11-30 0001348362 lxrp:Fiscal2020ActivityMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsEightMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsFiveMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsFourMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsOneMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsSevenMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsSixMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsThreeMember 2019-09-01 2019-11-30 0001348362 lxrp:WarrantsTwoMember 2019-09-01 2019-11-30 0001348362 us-gaap:CommonStockMember 2019-09-01 2019-11-30 0001348362 lxrp:StockOptionsOneMember 2019-09-01 2019-11-30 0001348362 lxrp:StockOptionsTwoMember 2019-09-01 2019-11-30 0001348362 lxrp:CorporateDevelopmentMember 2019-09-01 2019-11-30 0001348362 lxrp:CorporateDevelopmentTwoMember 2019-09-01 2019-11-30 0001348362 lxrp:InvestorRelationsAndCommunicationsAlexBlanchardCapitalMember 2019-09-01 2019-11-30 0001348362 lxrp:OfficeManagementMember 2019-09-01 2019-11-30 0001348362 lxrp:OfficeRentMember 2019-09-01 2019-11-30 0001348362 us-gaap:ResearchAndDevelopmentArrangementMember 2019-09-01 2019-11-30 0001348362 lxrp:BoardOfDirectorFeesMember 2019-09-01 2019-11-30 0001348362 lxrp:CABFinancialServicesMember 2019-09-01 2019-11-30 0001348362 lxrp:DochertyManagementLimitedMember 2019-09-01 2019-11-30 0001348362 lxrp:MEServicesLtdMember 2019-09-01 2019-11-30 0001348362 lxrp:ConsumerProductsMember 2019-09-01 2019-11-30 0001348362 lxrp:IntellectualPropertyLicensingMember 2019-09-01 2019-11-30 0001348362 us-gaap:CorporateMember 2019-09-01 2019-11-30 0001348362 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2019-11-30 0001348362 us-gaap:CommonStockMember 2019-09-01 2019-11-30 0001348362 us-gaap:NoncontrollingInterestMember 2019-09-01 2019-11-30 0001348362 us-gaap:RetainedEarningsMember 2019-09-01 2019-11-30 0001348362 us-gaap:WarrantMember 2019-09-01 2019-11-30 0001348362 us-gaap:PrivatePlacementMember 2019-09-01 2019-11-30 0001348362 lxrp:BrokerMember 2019-09-01 2019-11-30 0001348362 2019-11-30 0001348362 lxrp:AltriaVenturesIncMember 2019-11-30 0001348362 lxrp:LexariaNicotineLLCMember 2019-11-30 0001348362 lxrp:Fiscal2020ActivityMember 2019-11-30 0001348362 lxrp:PeriodAmortizationMember 2019-11-30 0001348362 lxrp:WarrantsEightMember 2019-11-30 0001348362 lxrp:WarrantsFiveMember 2019-11-30 0001348362 lxrp:WarrantsFourMember 2019-11-30 0001348362 lxrp:WarrantsOneMember 2019-11-30 0001348362 lxrp:WarrantsSevenMember 2019-11-30 0001348362 lxrp:WarrantsSixMember 2019-11-30 0001348362 lxrp:WarrantsThreeMember 2019-11-30 0001348362 lxrp:WarrantsTwoMember 2019-11-30 0001348362 us-gaap:AccountsPayableMember 2019-11-30 0001348362 us-gaap:AccruedLiabilitiesMember 2019-11-30 0001348362 us-gaap:CommonStockMember 2019-11-30 0001348362 lxrp:StockOptionsOneMember 2019-11-30 0001348362 lxrp:StockOptionsTwoMember 2019-11-30 0001348362 lxrp:DirectorsOfficersEmployeesAndConsultantsMember lxrp:TwoZeroOneFourStockOptionPlanMember 2019-11-30 0001348362 lxrp:OfficersAndEmployeesMember lxrp:TwoZeroOneZeroStockOptionPlanMember 2019-11-30 0001348362 lxrp:CorporateDevelopmentMember 2019-11-30 0001348362 lxrp:CorporateDevelopmentTwoMember 2019-11-30 0001348362 lxrp:InvestorRelationsAndCommunicationsAlexBlanchardCapitalMember 2019-11-30 0001348362 lxrp:OfficeManagementMember 2019-11-30 0001348362 lxrp:OfficeRentMember 2019-11-30 0001348362 us-gaap:ResearchAndDevelopmentArrangementMember 2019-11-30 0001348362 lxrp:EmployeesAndDirectorsMember lxrp:TwoZeroZeroSevenEquityIncentivePlanMember 2019-11-30 0001348362 lxrp:LabEquipmentMember 2019-11-30 0001348362 lxrp:PeriodAmortizationMember lxrp:LabEquipmentMember 2019-11-30 0001348362 us-gaap:ComputerEquipmentMember 2019-11-30 0001348362 lxrp:PeriodAmortizationMember us-gaap:ComputerEquipmentMember 2019-11-30 0001348362 us-gaap:FurnitureAndFixturesMember 2019-11-30 0001348362 lxrp:PeriodAmortizationMember us-gaap:FurnitureAndFixturesMember 2019-11-30 0001348362 us-gaap:LeaseholdImprovementsMember 2019-11-30 0001348362 lxrp:PeriodAmortizationMember us-gaap:LeaseholdImprovementsMember 2019-11-30 0001348362 lxrp:CABFinancialServicesMember 2019-11-30 0001348362 lxrp:DochertyManagementLimitedMember 2019-11-30 0001348362 lxrp:MEServicesLtdMember 2019-11-30 0001348362 lxrp:ConsumerProductsMember 2019-11-30 0001348362 lxrp:IntellectualPropertyLicensingMember 2019-11-30 0001348362 us-gaap:CorporateMember 2019-11-30 0001348362 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001348362 us-gaap:CommonStockMember 2019-11-30 0001348362 us-gaap:NoncontrollingInterestMember 2019-11-30 0001348362 us-gaap:RetainedEarningsMember 2019-11-30 0001348362 srt:MaximumMember us-gaap:WarrantMember 2019-11-30 0001348362 srt:MinimumMember us-gaap:WarrantMember 2019-11-30 0001348362 lxrp:DirectorsOfficersEmployeesAndConsultantsMember 2019-11-30 0001348362 lxrp:BrokerMember 2019-11-30 0001348362 us-gaap:SubsequentEventMember 2019-12-01 2020-01-02 0001348362 2020-01-08 iso4217:CAD iso4217:USD iso4217:USD shares pure shares 0001348362 --08-31 Accelerated Filer false 2020 Q1 true false Yes false

P20Y

10-Q 2019-11-30 Lexaria Bioscience Corp. Yes 80720879

1333321

1285147

1727184

2644860

22640

64214

325901

273145

133556

127396

96067

68927

1911485

1818829

269416

265127

565172

591263

226639

51777

28158

284689

213899

46857

26399

278017

834588

856390

2746073

2675219

678429

133556

1934088

93029

136411

37200

48096

130229

184507

130229

184507

220000000

0.001

80610879

78787134

80610879

78787134

80611

78787

27220524

26172453

-24775515

-23868202

2525620

2383038

90224

107674

2615844

2490712

67976

16108270

-13169939

-238476

2767831

75533

22095682

-19768782

-14247

2388186

78787

26172453

-23868202

107674

80611

27220524

-24775515

90224

2746073

2675219

62082

22209

10015

2257

51750

19902

317

37750

18000

19902

51750

10332

7853

2158

7853

54229

20051

19036

9572

46268

171913

483796 242991 17515

52355

96652

74027

72902

107463

96973

21853

19206

87593

-41574

-9630

978992

721442

104678

42020

832294

-924763

-701391

-52928

-39541

-832294

-907313

-701391

-6598843

-10344

-6609187

-4099420

-907313

-17450

-318820

248820

-70000

-58993

-17450

-0.01

79097349

76226802

-924763

-701391

162414

64044

27512

1603

70752

-57269

5365

6160

29435

27140

-10302

-43382

72499

-10896

13799

-652820

-564314

5710

44368

122832

-5710

-167200

706704

1649190

706704

1649190

48174

917676

957

110025 245 109780

67975761

75533471

78787134

80610879

647690

250000

648

780408

781056

250

234250

234500

2602239

626692

162414

1063270 1063270 52817 52817 70752 70752

545875

430000

-430000

110000

546

93156

93702

430

65820

66250

11000

6364145 1626513 6363 1767159 1773522 1627 794496 796123

-14247

14247

947150

1579245

947

1469363

1470310

1579

705125

706704

833333 166667 1000000 244500

1. Organization, Business and Going Concern Lexaria Bioscience Corp. (“Lexaria”, or the “Company”) was formed on December 9, 2004 under the laws of the State of Nevada. In March of 2014, the Company began its entry into the bioscience and alternative health and wellness business and in May 2016, the Company commenced out-licensing its patented DehydraTECH™ technology (the “Technology”) for improved delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company has its office in Kelowna, BC, Canada. The Company’s unaudited interim consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles (US GAAP) have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for a full year. These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated annual financial statements and notes thereto included in our annual report filed on Form 10-K for the year ended August 31, 2019. The Company’s unaudited interim consolidated financial statements have been prepared in accordance with US GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The recurring losses from operations and net capital deficiency raise substantial doubt about the Company’s ability to continue as a going concern. The Company requires additional funds or revenues to maintain its operations and developments. Management’s plans in this regard are to raise equity and debt financing as required, but there is no certainty that such financing will be available or that it will be available at acceptable terms. The outcome of these matters cannot be predicted at this time.

2. Business Risk and Liquidity The Company is subject to several categories of risk associated with its operating activities. The production and sale of alternative health products is an emerging industry in which business practices are not yet standardized and are subject to frequent scrutiny and evaluation by federal, state, provincial, and municipal authorities, academics, and media outlets, among others. Although we intend to develop our businesses in accordance with best ethical practices, we may suffer negative publicity if we, our partners, contractors, or customers are found to have engaged in any environmentally insensitive practices or other business practices that are viewed as unethical. Our operations may require licenses and permits from various governmental authorities. We believe that we will be able to obtain all necessary licenses and permits under applicable laws and regulations for our operations and believe we will be able to comply in all material respects with the terms of such licenses and permits. However, such licenses and permits are subject to change in various circumstances. There can be no guarantee that we will be able to obtain or maintain all necessary licenses and permits, and failing to obtain or retain required licenses could have a materially adverse effect on the Company. Lexaria and its subsidiaries are not involved directly or indirectly in the cultivation, processing, distribution, or utilization of cannabis or cannabis derived components. All of Lexaria’s consumer products utilize legally sourced hemp and hemp components in their production. Lexaria does have an ancillary involvement risk via out-licensing of its patented technology to licensees that choose to utilize its Technology to manufacture products that contain locally or state approved but federally regulated and controlled contents. There can be no guarantee that changes in the regulatory framework and environment will not occur and such changes could have a materially adverse effect on the Company. Lexaria and its subsidiaries are not involved directly or indirectly in the production or sale of any products containing nicotine. Products containing nicotine have historically been involved in litigation in the USA. Lexaria’s corporate licensee may introduce products containing nicotine that utilize Lexaria’s Technology to the US consumer market, which could therefore introduce third-party risks to Lexaria.

<div>3. Significant Accounting Policies<div> The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.</div></div>

<div>Significant Accounting Policies<div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"> The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.</div></div>

<div>Recent Accounting Guidance In February 2016 FASB issued ASU No. 201602, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and the lessors. The new standard requires the lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right of use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2020. When adopted, the Company does not expect this guidance to have a material impact on its consolidated financial statements. In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available for sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2022. Application of the amendments is through a cumulative effect adjustment to deficit as of the effective date. The Company is currently assessing the impact of the standard on its consolidated financial statements. In February 2018, the FASB issued ASU No. 201802, Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted by the U.S. federal government on December 22, 2017 (the “2017 Tax Act”). Consequently, the amendments eliminate the stranded tax effects resulting from the 2017 Tax Act and will improve the usefulness of information reported to financial statement users. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company adopted the ASU on September 1, 2019 for a $NIL effect. In June 2018, the FASB issued ASU No. 201807, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share Based Payment Accounting. This is a simplification that involves several aspects of accounting for nonemployee share-based payments resulting from expanding the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the ASU on September 1, 2019 for a $NIL effect.</div>

4. Basis of Consolidation These consolidated financial statements include the financial statements of the Company and its wholly owned subsidiaries; Lexaria CanPharm ULC, PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp. and Lexaria Pharmaceutical Corp., and our 83.333% subsidiary Lexaria Nicotine LLC (16.667% Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc.). All significant intercompany balances and transactions have been eliminated.

0.83333

0.16667

5. Estimates and Judgments The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company’s accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. In preparing these unaudited interim consolidated financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended August 31, 2019.

6. Recent Accounting Guidance In February 2016 FASB issued ASU No. 201602, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and the lessors. The new standard requires the lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right of use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2020. When adopted, the Company does not expect this guidance to have a material impact on its consolidated financial statements. In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available for sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2022. Application of the amendments is through a cumulative effect adjustment to deficit as of the effective date. The Company is currently assessing the impact of the standard on its consolidated financial statements. In February 2018, the FASB issued ASU No. 201802, Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted by the U.S. federal government on December 22, 2017 (the “2017 Tax Act”). Consequently, the amendments eliminate the stranded tax effects resulting from the 2017 Tax Act and will improve the usefulness of information reported to financial statement users. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company adopted the ASU on September 1, 2019 for a $NIL effect. In June 2018, the FASB issued ASU No. 201807, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share Based Payment Accounting. This is a simplification that involves several aspects of accounting for nonemployee share-based payments resulting from expanding the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

7. Accounts and Other Receivables <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">November 302019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">August 312019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Trade and deposits receivable</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,458</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,727</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Territory license fee receivable</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">124,324</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">106,000</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Sales tax receivable</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">86,094</td><td style="padding-bottom:1px;width:1%;background-color:rgb(204, 238, 255);border:1pt none" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255);border:1pt none" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">161,418</td><td style="padding-bottom:1px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Subscription receivable</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">110,025</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255);border:1pt none" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255);border:1pt none" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">—</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">325,901</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">273,145</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">November 302019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">August 312019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Trade and deposits receivable</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,458</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,727</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Territory license fee receivable</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">124,324</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">106,000</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Sales tax receivable</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">86,094</td><td style="padding-bottom:1px;width:1%;background-color:rgb(204, 238, 255);border:1pt none" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255);border:1pt none" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">161,418</td><td style="padding-bottom:1px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Subscription receivable</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">110,025</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255);border:1pt none" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255);border:1pt none" valign="bottom"> </td><td style="border:1pt none;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">—</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">325,901</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">273,145</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table> 5458 5727 124324 106000

86094

161418

110025 0

8. Inventory <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">November 302019$</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">August 312019$</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Raw materials</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">58,806</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">45,068</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Finished goods</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">74,750</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">82,328</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">133,556</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">127,396</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table> During the period ended November 30, 2019, the Company wrote down $NIL (2019 - $7,182) of inventory to reflect its net realisable value.

58806

45068

74750

82328

7182

9. Intellectual Property The following is a list of US capitalized patents held by the Company <table border="0" cellpadding="0" cellspacing="0" style="BORDER-RIGHT:black 1px solid;BORDER-BOTTOM:black 1px solid;TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="94%"><tbody><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%" valign="top">Issued Patent #</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%" valign="top">Patent Issuance Date</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:39%" valign="top">Patent Family</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 9,474,725 B1</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">10/25/2016</td><td colspan="1" rowspan="8" style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:39%" valign="top"> Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 9,839,612 B2</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">12/12/2017</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 9,972,680 B2</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">05/15/2018</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 9,974,739 B2</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">05/22/2018</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 10,084,044 B2</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">09/25/2018</td></tr><tr style="height:15"><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:17%">US 10,103,225 B2</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">10/16/2018</td></tr><tr><td style="border-top:1px solid black;border-left:1px solid black;width:17%;text-align:center">US 10,381,440</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">08/13/2019</td></tr><tr><td style="border-top:1px solid black;border-left:1px solid black;width:17%;text-align:center">US 10,374,036</td><td style="BORDER-TOP:black 1px solid;BORDER-LEFT:black 1px solid;width:20%">08/06/2019</td></tr></tbody></table> The Company also holds non-capitalized patents outside the US. A continuity schedule for capitalized patents is presented below: <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">August 312019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance – beginning</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">265,127</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">146,538</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Additions</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">5,710</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">122,982</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Amortization*</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(1,421</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(4,393</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td></tr><tr style="background-color:#ffffff"><td valign="top">Balance – ending</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">269,416</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">265,127</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table> * The patents are amortized over their legal life of 20 years.

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">August 312019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance – beginning</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">265,127</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">146,538</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Additions</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">5,710</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">122,982</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Amortization*</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(1,421</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(4,393</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td></tr><tr style="background-color:#ffffff"><td valign="top">Balance – ending</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">269,416</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">265,127</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table>

265127

146538

269416

5710

122982

1421

4393

10. Property Equipment<div> <table style="width:92%;background:white;border:0px;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Net Balance </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Year Ended August 31, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">Cost</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">PeriodAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AccumulatedAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">August 31,2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Leasehold improvements</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">259,981</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(33,342</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(33,342</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">226,639</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Computers</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">63,964</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(12,187</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(12,187</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">51,777</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Furniture fixtures equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">34,220</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(4,205</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(6,062</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">28,158</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Lab equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">291,235</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,546</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,546</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">284,689</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">649,400</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(56,281</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(58,137</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">591,263</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td></tr></tbody></table> <table style="width:92%;background:white;border:0px;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Net Balance</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Quarter Ended November 30, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">Cost</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AmortizationPeriod</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AccumulatedAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">November 30, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Leasehold improvements</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">259,981</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(12,740</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(46,082</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">213,899</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Computers</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">63,964</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(4,920</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(17,107</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">46,857</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Furniture fixtures equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">34,220</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(1,759</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(7,821</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">26,399</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Lab equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">291,235</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,672</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(13,218</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">278,017</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">649,400</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(26,091</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(84,228</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">565,172</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td></tr></tbody></table></div>

<div> <table style="width:92%;background:white;border:0px;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Net Balance </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Year Ended August 31, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">Cost</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">PeriodAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AccumulatedAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">August 31,2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Leasehold improvements</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">259,981</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(33,342</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(33,342</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">226,639</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Computers</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">63,964</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(12,187</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(12,187</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">51,777</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Furniture fixtures equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">34,220</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(4,205</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(6,062</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">28,158</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Lab equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">291,235</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,546</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,546</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">284,689</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">649,400</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(56,281</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(58,137</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">591,263</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td></tr></tbody></table> <table style="width:92%;background:white;border:0px;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Net Balance</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">Quarter Ended November 30, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">Cost</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AmortizationPeriod</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">AccumulatedAmortization</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="bottom">November 30, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255);width:9%" valign="bottom">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Leasehold improvements</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">259,981</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(12,740</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">(46,082</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:9%" valign="bottom">213,899</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Computers</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">63,964</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(4,920</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(17,107</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">46,857</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(204, 238, 255)" valign="top">Furniture fixtures equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">34,220</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(1,759</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">(7,821</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9%" valign="bottom">26,399</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:13px;background-color:rgb(255, 255, 255)" valign="top">Lab equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">291,235</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(6,672</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">(13,218</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9%" valign="bottom">278,017</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:1%" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">649,400</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(26,091</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">(84,228</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:9%" valign="bottom">565,172</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:1%" valign="bottom"> </td></tr></tbody></table></div>

259981

63964

34220

291235

649400

259981

63964

34220

291235

649400

33342

12187

4205

6062

6546

56281

58137

12740

46082

4920

17107

1759

7821

6672

13218

26091

84228

11. Accounts Payable and Accrued Liabilities <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td style="width:556px" valign="bottom"> </td><td style="width:9px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:78px" valign="bottom">November 302019$</td><td valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:73px" valign="bottom">August 312019$</td><td valign="bottom"> </td></tr><tr><td style="width:556px" valign="top">Accounts Payable</td><td style="width:9px" valign="bottom"> </td><td colspan="2" style="text-align:right;width:78px" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td colspan="2" style="text-align:right;width:73px" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:556px" valign="top"> Trades payable</td><td style="width:9px" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="text-align:right;width:75.5px" valign="bottom">89,254</td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="width:8px" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">31,463</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="width:556px" valign="top"> Sales tax payable</td><td style="width:9px" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="text-align:right;width:75.5px" valign="bottom">—</td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="width:8px" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">63,616</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:556px" valign="top">Accrued Liabilities</td><td style="width:9px" valign="bottom"> </td><td style="border:1pt none;width:6px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:75.5px" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border:1pt none;width:8px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr><td style="width:556px" valign="top"> Trades payable</td><td style="width:9px" valign="bottom"> </td><td style="border:1pt none;width:6px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:75.5px" valign="bottom">3,775</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border:1pt none;width:8px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%" valign="bottom">41,332</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="width:556px">Balance – Ending</td><td style="width:9px" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:6px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:75.5px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">93,029</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:8px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">136,411</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr></tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td style="width:556px" valign="bottom"> </td><td style="width:9px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:78px" valign="bottom">November 302019$</td><td valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:73px" valign="bottom">August 312019$</td><td valign="bottom"> </td></tr><tr><td style="width:556px" valign="top">Accounts Payable</td><td style="width:9px" valign="bottom"> </td><td colspan="2" style="text-align:right;width:78px" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td colspan="2" style="text-align:right;width:73px" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:556px" valign="top"> Trades payable</td><td style="width:9px" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="text-align:right;width:75.5px" valign="bottom">89,254</td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="width:8px" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">31,463</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="width:556px" valign="top"> Sales tax payable</td><td style="width:9px" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="text-align:right;width:75.5px" valign="bottom">—</td><td style="width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="width:8px" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">63,616</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:556px" valign="top">Accrued Liabilities</td><td style="width:9px" valign="bottom"> </td><td style="border:1pt none;width:6px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:75.5px" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border:1pt none;width:8px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr><td style="width:556px" valign="top"> Trades payable</td><td style="width:9px" valign="bottom"> </td><td style="border:1pt none;width:6px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:75.5px" valign="bottom">3,775</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border:1pt none;width:8px" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:9%" valign="bottom">41,332</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="width:556px">Balance – Ending</td><td style="width:9px" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:6px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:75.5px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">93,029</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:6px" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:8px;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">136,411</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr></tbody></table>

89254

31463

3775

41332

63616

12. Common Shares and Warrants Fiscal 2020 ActivityDuring the period ended November 30, 2019 the Company closed, pursuant to two tranches, a non-brokered private placement for an aggregate total of 1,823,745 Units priced at $0.45 each. Each Unit consists of one common share and one Share purchase warrant. Each warrant shall entitle the holder to acquire one common share of the Company for a period of two years at a price of $0.80 per Share until the first anniversary of issuance for a period of 12 months, and thereafter at a price of $1.20 for an additional 12 months until November 13, 2021 until the second anniversary of issuance. The Company paid $3,937.50 and issued 8,750 broker warrants. The broker warrants have a term of 24 months and are each exercisable into one common share of the Company at a price of $0.80 per Share until the first anniversary of issuance, and thereafter at a price of $1.20 until the second anniversary of issuance. The fair value of these broker warrants was determined to be $1,850, which were recorded as a share issuance cost within additional paid in capital for a net effect of $Nil. During the period ended November 30, 2019 the Company recognized $70,752 in consulting expense for warrants granted to a consultant on vesting. A summary of share issuance relating to option and warrant exercises, agreement requirements and debt settlement is presented below:<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom">Type of Issuance</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">Number of Shares</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">Total Value</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Private placement</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,823,745</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">820,685</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">1,823,745</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">$</td><td style="border-top:1px solid;border-bottom:3px double;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">820,685</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr></tbody></table></div> A continuity schedule for warrants is presented below: <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Number of Warrants</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Weighted Average Exercise Price$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance, August 31, 2018</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">3,286,274</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.72</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Cancelled/Expired</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(17,498</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.59</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Exercised</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(1,626,513</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.49</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Issued</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">1,183,062</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">1.99</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance, August 31, 2019</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">2,825,325</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">1.38</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Issued</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">2,057,495</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">0.80</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance November 30, 2019</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">4,882,820</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">1.14</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table></div> The fair value of share purchase warrants granted as broker warrants, compensation units, and compensatory warrants, was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">November 302019</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected volatility</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">91%</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="bottom">Risk-free interest rate</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">2.87%</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected life</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">2 years</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Dividend yield</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:11%" valign="bottom">0.00%</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Estimated fair value per warrant</td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double"> </td><td style="BORDER-BOTTOM:black 3px double">$0.28 - $0.43</td><td style="PADDING-BOTTOM:3px" valign="bottom"> </td></tr></tbody></table></div> A summary of warrants outstanding as of November 30, 2019 is presented below:<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"># of Warrants</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Remaining Contractual Life</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Exercise Price $</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">250,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">0.01 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">0.83</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">500,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)">0.13 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">1.83</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">975,325</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">0.92 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">2.25</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">100,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)">1.48 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">0.96</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">250,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">1.48 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">1.55</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:center;background-color:rgb(255, 255, 255)">750,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(255, 255, 255)">1.86 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">0.14</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="text-align:center;background-color:rgb(204, 238, 255)">225,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(204, 238, 255)">2.00 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(204, 238, 255)" valign="bottom">0.80</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)">1,832,495</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)">2.00 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">0.80</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)">4,882,820</td><td style="padding-bottom:1px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)">1.46 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">1.14</td></tr></tbody></table></div>

1823745 0.45 1

0.80 P12M P24M

1.20

3937.50

8750

0.80

0.83

1.83

2.25

0.96

1.55

0.14

0.80

1.14

1850 <div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom">Type of Issuance</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">Number of Shares</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">Total Value</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Private placement</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,823,745</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">820,685</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">1,823,745</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1px solid;border-bottom:3px double;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">$</td><td style="border-top:1px solid;border-bottom:3px double;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">820,685</td><td style="padding-bottom:1px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr></tbody></table></div> 1823745 1823745 820685 820685 <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Number of Warrants</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Weighted Average Exercise Price$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance, August 31, 2018</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">3,286,274</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.72</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Cancelled/Expired</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(17,498</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.59</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Exercised</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(1,626,513</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">0.49</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Issued</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">1,183,062</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">1.99</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance, August 31, 2019</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">2,825,325</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">1.38</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Issued</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">2,057,495</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">0.80</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Balance November 30, 2019</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">4,882,820</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">1.14</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table></div>

3286274

2825325

4882820

250000

500000

975325

100000

250000

750000

225000

1832495

0.72 1.38 1.14 17498 0.59 1626513 0.49 1183062 2057495 1.99 0.80 <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">November 302019</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected volatility</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">91%</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="bottom">Risk-free interest rate</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">2.87%</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected life</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">2 years</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Dividend yield</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:11%" valign="bottom">0.00%</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Estimated fair value per warrant</td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double"> </td><td style="BORDER-BOTTOM:black 3px double">$0.28 - $0.43</td><td style="PADDING-BOTTOM:3px" valign="bottom"> </td></tr></tbody></table></div>

0.91

0.96

0.0287

0.0166

P2Y

P5Y

0.0000

0.28

0.43

<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"># of Warrants</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Remaining Contractual Life</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Exercise Price $</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">250,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">0.01 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">0.83</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">500,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)">0.13 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">1.83</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">975,325</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">0.92 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">2.25</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">100,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)">1.48 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">0.96</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)">250,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)">1.48 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">1.55</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:center;background-color:rgb(255, 255, 255)">750,000</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(255, 255, 255)">1.86 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">0.14</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="text-align:center;background-color:rgb(204, 238, 255)">225,000</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(204, 238, 255)">2.00 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:center;background-color:rgb(204, 238, 255)" valign="bottom">0.80</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)">1,832,495</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)">2.00 years</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">0.80</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)">4,882,820</td><td style="padding-bottom:1px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)">1.46 years</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">1.14</td></tr></tbody></table></div>

P0Y3D P0Y1M17D P0Y11M1D P1Y5M23D P1Y5M23D P1Y10M9D P2Y P2Y P1Y5M15D

<div>13. Stock Options The Company has established its 2007 Equity Incentive Plan, whereby the board of directors may grant up to 412,500 stock options to eligible employees and directors, the 2010 Stock Option Plan whereby the board of directors may, from time to time, grant up to 1,512,500 stock options to officers and employees; the 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 2,107,500 stock options to directors, officers, employees, and consultants; and the 2019 Equity Incentive Plan whereby the board of directors may, from time to time, grant up to 7,838,713 stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors. Fiscal 2020 Activity The Company granted in the period ending November 30, 2019: <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td style="BORDER-BOTTOM:black 1px solid" valign="bottom">Quantity</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">Exercise Price $</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">Life (Years)</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:31%">500,000(1)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:31%;text-align:center" valign="bottom">0.55</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:31%;text-align:center" valign="bottom">5</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="BORDER-BOTTOM:black 1px solid">500,000(2)</td><td valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center" valign="bottom">0.55</td><td valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center" valign="bottom">5</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="BORDER-BOTTOM:black 3px double">1,000,000</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:center" valign="bottom">0.55</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right" valign="bottom"> </td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr></tbody></table> __________(1)Options granted vest 50,000 on grant and the remainder based on contracted milestones(2)Options granted vest 250,000 on grant and the remainder based on contracted milestones A continuity schedule for stock options is presented below: <table border="0" cellpadding="0" cellspacing="0" style="text-align:justify;font:10pt Times New Roman;margin:auto;width:691px" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:1px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:67px;background-color:rgb(255, 255, 255)" valign="bottom">Options</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:8px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:3px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:85px;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Exercise Price$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:10px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:9px" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;width:74px;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Remaining Contractual Term (Years)</td><td style="background-color:rgb(255, 255, 255);width:6px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:95px;background-color:rgb(255, 255, 255)" valign="bottom">Aggregate Intrinsic Value$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:1px" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance August 31, 2018</td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">4,800,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">0.71</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px">Expired/cancelled</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)">(1,415,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)">)</td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)">0.66</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Exercised</td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">(430,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">)</td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">0.15</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Granted</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">2,048,000</td><td style="padding-bottom:1px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">1.00</td><td style="padding-bottom:1px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:74px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;padding-bottom:1px;width:6px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border:1pt none;text-align:right;width:95px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:1px;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance August 31, 2019</td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">5,003,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">0.89</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Granted</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">1,000,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">0.55</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:74px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:3px;width:6px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border:1pt none;text-align:right;width:95px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:3px;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance November 30, 2019 (Outstanding)</td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:23px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:48px;background-color:rgb(204, 238, 255)" valign="bottom">6,003,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:56px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:30px;background-color:rgb(204, 238, 255)" valign="bottom">0.84</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255);width:74px">3.41</td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:25px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:73.5px;background-color:rgb(204, 238, 255)" valign="bottom">931,800</td><td style="padding-bottom:3px;width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Balance November 30, 2019 (Exercisable)</td><td style="width:1px;border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">4,261,341</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">0.88</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255);width:74px">2.94</td><td style="width:6px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:73.5px;background-color:rgb(255, 255, 255)" valign="bottom">794,300</td><td style="padding-bottom:3px;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr></tbody></table> The fair value of options granted was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:<div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">November 302019</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected volatility</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">96%</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="bottom">Risk-free interest rate</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">1.66%</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected life</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">5 years</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Dividend yield</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:12%" valign="bottom">0.00%</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Estimated fair value per option</td><td valign="bottom">$</td><td> </td><td>0.39</td><td style="PADDING-BOTTOM:3px" valign="bottom"> </td></tr></tbody></table></div></div>

412500

1512500

2107500

7838713

P5Y

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td style="BORDER-BOTTOM:black 1px solid" valign="bottom">Quantity</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">Exercise Price $</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">Life (Years)</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="width:31%">500,000(1)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:31%;text-align:center" valign="bottom">0.55</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:31%;text-align:center" valign="bottom">5</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td style="BORDER-BOTTOM:black 1px solid">500,000(2)</td><td valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center" valign="bottom">0.55</td><td valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center" valign="bottom">5</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td style="BORDER-BOTTOM:black 3px double">1,000,000</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:center" valign="bottom">0.55</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right" valign="bottom"> </td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr></tbody></table> __________(1)Options granted vest 50,000 on grant and the remainder based on contracted milestones(2)Options granted vest 250,000 on grant and the remainder based on contracted milestones

500000

1000000

0.55

0.15

P5Y P5Y

50000

250000

<table border="0" cellpadding="0" cellspacing="0" style="text-align:justify;font:10pt Times New Roman;margin:auto;width:691px" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:1px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:67px;background-color:rgb(255, 255, 255)" valign="bottom">Options</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:8px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:3px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:85px;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Exercise Price$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:10px" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255);width:9px" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:center;width:74px;background-color:rgb(255, 255, 255)" valign="bottom">Weighted Average Remaining Contractual Term (Years)</td><td style="background-color:rgb(255, 255, 255);width:6px" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:95px;background-color:rgb(255, 255, 255)" valign="bottom">Aggregate Intrinsic Value$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255);width:1px" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance August 31, 2018</td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">4,800,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">0.71</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px">Expired/cancelled</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)">(1,415,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)">)</td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)">0.66</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Exercised</td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">(430,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">)</td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom">0.15</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Granted</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">2,048,000</td><td style="padding-bottom:1px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">1.00</td><td style="padding-bottom:1px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:74px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;padding-bottom:1px;width:6px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border:1pt none;text-align:right;width:95px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:1px;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance August 31, 2019</td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:23px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:48px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">5,003,000</td><td style="width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:56px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:30px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">0.89</td><td style="width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:9px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:74px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;width:95px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Granted</td><td style="width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">1,000,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">0.55</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;text-align:right;width:74px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:3px;width:6px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border:1pt none;text-align:right;width:95px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="padding-bottom:3px;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255);width:378px" valign="top">Balance November 30, 2019 (Outstanding)</td><td style="width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:23px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:48px;background-color:rgb(204, 238, 255)" valign="bottom">6,003,000</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:56px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:30px;background-color:rgb(204, 238, 255)" valign="bottom">0.84</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255);width:74px">3.41</td><td style="width:6px;border:1pt none;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;width:25px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;text-align:right;width:73.5px;background-color:rgb(204, 238, 255)" valign="bottom">931,800</td><td style="padding-bottom:3px;width:1px;border-width:1pt;border-style:solid none none;border-top-color:black;border-right-color:initial;border-bottom-color:initial;border-left-color:initial;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255);width:378px" valign="top">Balance November 30, 2019 (Exercisable)</td><td style="width:1px;border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:23px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:48px;background-color:rgb(255, 255, 255)" valign="bottom">4,261,341</td><td style="padding-bottom:3px;width:8px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:3px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:56px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:30px;background-color:rgb(255, 255, 255)" valign="bottom">0.88</td><td style="padding-bottom:3px;width:10px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border:1pt none;width:9px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255);width:74px">2.94</td><td style="width:6px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;text-align:right;width:73.5px;background-color:rgb(255, 255, 255)" valign="bottom">794,300</td><td style="padding-bottom:3px;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2.5pt double black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr></tbody></table>

4800000

5003000

6003000

0.71

0.89

0.84

1415000

0.66

2048000

1000000

1.00

0.55

P3Y4M28D

931800

4261341

0.88

P2Y11M8D

794300

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center" valign="bottom">November 302019</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected volatility</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">96%</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="bottom">Risk-free interest rate</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">1.66%</td><td valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="bottom">Expected life</td><td valign="bottom"> </td><td> </td><td style="text-align:center" valign="bottom">5 years</td><td valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Dividend yield</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:12%" valign="bottom">0.00%</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Estimated fair value per option</td><td valign="bottom">$</td><td> </td><td>0.39</td><td style="PADDING-BOTTOM:3px" valign="bottom"> </td></tr></tbody></table>

0.39

14. Revenues <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302018$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Product sales</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">10,015</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">2,257</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Licensing revenue</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">51,750</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">19,902</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Freight revenue</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">317</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">50</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">62,082</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">22,209</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table> During the period ended November 30, 2019, the Company recognized $37,750 of Intellectual Property Licensing fees and $18,000 of Usage Fees (November 2018 -$Nil and $19,902). Licensing revenues are significantly concentrated on a single customer. There was an increase in product sales in the current year compared to the previous years as the Company was able to solve some payment processing issues late in fiscal 2019, allowing for improved ability to conduct retail transactions. The Licensing fees consist of IP licensing fees for transfer of the Technology with the signing of definitive agreements for the DehydraTECH technology and usage fees. The Licensing fees include payments due upon transfer of the Technology and installment payments that are receivable within 12 months (Note 7).

<table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302019$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">November 302018$</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Product sales</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">10,015</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">2,257</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Licensing revenue</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">51,750</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">19,902</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Freight revenue</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">317</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">50</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">62,082</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">22,209</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table>

15. Related Party Transactions <div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Nov 302019Total$</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Nov 302018Total$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Management, consulting and accounting services</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:34%;background-color:rgb(204, 238, 255)" valign="top">C.A.B Financial Services(1)</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:8%;background-color:rgb(204, 238, 255)" valign="bottom">65,757</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:8%;background-color:rgb(204, 238, 255)" valign="bottom">36,000</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">ME Services Ltd.(1)</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">29,382</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">27,422</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Docherty Management Limited(1)</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">56,730</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">34,278</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Directors</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">16,717</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">—</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">168,586</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">97,700</td><td style="padding-bottom:3px;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table> </div><div>(1) C.A.B. Financial Services is owned by the CEO of the Company, ME Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.</div> Due to related parties: As at November 30, 2019, $37,200 (August 31, 2019 - $48,096) was payable to related parties included in due to related parties. The related party transactions are recorded at the exchange amount established and agreed to between the related parties.

<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Nov 302019Total$</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom">Nov 302018Total$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Management, consulting and accounting services</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:34%;background-color:rgb(204, 238, 255)" valign="top">C.A.B Financial Services(1)</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:8%;background-color:rgb(204, 238, 255)" valign="bottom">65,757</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:8%;background-color:rgb(204, 238, 255)" valign="bottom">36,000</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">ME Services Ltd.(1)</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">29,382</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">27,422</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)" valign="top">Docherty Management Limited(1)</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">56,730</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">34,278</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)" valign="top">Directors</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">16,717</td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="border-bottom:1px solid black;text-align:right;background-color:rgb(255, 255, 255)" valign="bottom">—</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="background-color:rgb(204, 238, 255)"> </td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">168,586</td><td style="background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:3px double black;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">97,700</td><td style="padding-bottom:3px;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table> </div><div>(1) C.A.B. Financial Services is owned by the CEO of the Company, ME Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.</div>

65757

36000

29382

27422

56730

34278

16717

168586

97700

16. Segment Information The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on one licensee. <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">IP Licensing</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Consumer Products</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Corporate</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Consolidated Total</td><td style="PADDING-BOTTOM:1px" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">External revenue</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">51,750</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">10,332</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">—</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">62,082</td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">CoGS</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">—</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(7,853</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">—</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(7,853</td><td style="width:1%" valign="bottom">)</td></tr><tr style="background-color:#cceeff"><td valign="top">Operating expenses</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(104,678</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(42,020</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(832,294</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom">(978,992</td><td style="width:1%" valign="bottom">)</td></tr><tr style="background-color:#ffffff"><td valign="top">Segment loss</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(52,928</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(39,541</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(832,294</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(924,763</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td></tr><tr style="background-color:#cceeff"><td valign="top">Total assets</td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">678,429</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">133,556</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">1,934,088</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">2,746,073</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table>

17. Commitments, Significant Contracts and Contingencies Management and Service Agreements: As at November 30, 2019, the Company is party to the following contractual commitments:<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="height:15"><td style="BORDER-BOTTOM:black 1px solid" valign="top">Party</td><td style="width:2%"> </td><td style="BORDER-BOTTOM:black 1px solid;width:22%" valign="top">Monthly Commitment</td><td style="width:2%"> </td><td style="BORDER-BOTTOM:black 1px solid;width:22%">Expiry Date</td><td style="width:1%" valign="top"> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">C.A.B Financial Services</td><td valign="top"> </td><td valign="top">CAD $29,167</td><td> </td><td valign="top">January 1, 2022</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Docherty Management Ltd.</td><td valign="top"> </td><td valign="top">CAD $25,000</td><td> </td><td valign="top">January 1, 2022</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">ME Services Ltd.</td><td valign="top"> </td><td valign="top">CAD $12,960</td><td> </td><td valign="top">June 1, 2021</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Corporate development</td><td valign="top"> </td><td valign="top">CAD $1,000</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Corporate development</td><td valign="top"> </td><td valign="top">CAD $8,000</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Investor relations and communications – Alex Blanchard Capital</td><td valign="top"> </td><td style="text-align:center" valign="top">CAD $7,500</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Office management</td><td valign="top"> </td><td valign="top">CAD $10,000</td><td> </td><td valign="top">August 15, 2022</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Research development</td><td valign="top"> </td><td valign="top">CAD $3,854</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Office rent(1)</td><td valign="top"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="top">CAD $4,823</td><td> </td><td style="BORDER-BOTTOM:black 1px solid" valign="top">November 15, 2023</td><td> </td></tr></tbody></table> Corporate Offices (1) Corporate office and RD lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.</div>

<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="height:15"><td style="BORDER-BOTTOM:black 1px solid" valign="top">Party</td><td style="width:2%"> </td><td style="BORDER-BOTTOM:black 1px solid;width:22%" valign="top">Monthly Commitment</td><td style="width:2%"> </td><td style="BORDER-BOTTOM:black 1px solid;width:22%">Expiry Date</td><td style="width:1%" valign="top"> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">C.A.B Financial Services</td><td valign="top"> </td><td valign="top">CAD $29,167</td><td> </td><td valign="top">January 1, 2022</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Docherty Management Ltd.</td><td valign="top"> </td><td valign="top">CAD $25,000</td><td> </td><td valign="top">January 1, 2022</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">ME Services Ltd.</td><td valign="top"> </td><td valign="top">CAD $12,960</td><td> </td><td valign="top">June 1, 2021</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Corporate development</td><td valign="top"> </td><td valign="top">CAD $1,000</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Corporate development</td><td valign="top"> </td><td valign="top">CAD $8,000</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Investor relations and communications – Alex Blanchard Capital</td><td valign="top"> </td><td style="text-align:center" valign="top">CAD $7,500</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Office management</td><td valign="top"> </td><td valign="top">CAD $10,000</td><td> </td><td valign="top">August 15, 2022</td><td> </td></tr><tr style="height:15;background-color:#ffffff"><td valign="top">Research development</td><td valign="top"> </td><td valign="top">CAD $3,854</td><td> </td><td valign="top">Month to Month</td><td> </td></tr><tr style="height:15;background-color:#cceeff"><td valign="top">Office rent(1)</td><td valign="top"> </td><td style="BORDER-BOTTOM:black 1px solid" valign="top">CAD $4,823</td><td> </td><td style="BORDER-BOTTOM:black 1px solid" valign="top">November 15, 2023</td><td> </td></tr></tbody></table> Corporate Offices (1) Corporate office and RD lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.</div>

29167

25000

12960

1000

8000

7500

10000

3854

4823

January 1, 2022 January 1, 2022 June 1, 2021 Month to Month Month to Month Month to Month August 15, 2022 Month to Month November 15, 2023 18. Prepaid Expenses Prepaid expenses consist of the following at November 30, 2019 and August 31, 2019: <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="width:551px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:12px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:83px;background-color:rgb(255, 255, 255)" valign="bottom">November 302019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">August 312019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:551px;background-color:rgb(204, 238, 255)" valign="top">Advertising Conferences</td><td style="width:12px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:17px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">54,587</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">39,143</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:551px;background-color:rgb(255, 255, 255)" valign="top">Office Insurance</td><td style="width:12px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:17px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">41,480</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">29,784</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:551px;background-color:rgb(204, 238, 255)"> </td><td style="width:12px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:17px;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">96,067</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">68,927</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table></div> <div><table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="width:551px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:12px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:83px;background-color:rgb(255, 255, 255)" valign="bottom">November 302019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="background-color:rgb(255, 255, 255)" valign="bottom"> </td><td colspan="2" style="border-bottom:1px solid black;text-align:center;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">August 312019$</td><td style="padding-bottom:1px;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:551px;background-color:rgb(204, 238, 255)" valign="top">Advertising Conferences</td><td style="width:12px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:17px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">54,587</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">39,143</td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:551px;background-color:rgb(255, 255, 255)" valign="top">Office Insurance</td><td style="width:12px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:17px;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">41,480</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td><td style="text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">29,784</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"> </td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:551px;background-color:rgb(204, 238, 255)"> </td><td style="width:12px;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:17px;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">96,067</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td><td style="border-bottom:2.5pt double black;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom"> </td><td style="border-bottom:2.5pt double black;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial" valign="bottom">68,927</td><td style="padding-bottom:3px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td></tr></tbody></table></div>

54587

39143

41480

29784

19. Marketable Securities The components of Marketable Securities were as follows:<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Cost Basis $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Unrealized Gains $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Unrealized Losses $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Total$</td><td valign="bottom"> </td></tr><tr><td valign="top">August 31, 2019</td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Common stock</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(12,124</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Total</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">(26,973</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">64,214</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">November 30, 2019</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Common stock</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(40,972</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Total</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">(67,945</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">22,640</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table></div> Unrealized losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence.

<div> <table border="0" cellpadding="0" cellspacing="0" style="TEXT-ALIGN:justify;FONT:10pt TIMES NEW ROMAN;margin:auto" width="92%"><tbody><tr><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Cost Basis $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Unrealized Gains $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Unrealized Losses $</td><td valign="bottom"> </td><td valign="bottom"> </td><td colspan="2" style="BORDER-BOTTOM:black 1px solid;text-align:center;width:9%" valign="bottom">Total$</td><td valign="bottom"> </td></tr><tr><td valign="top">August 31, 2019</td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td colspan="2" style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Common stock</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(12,124</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Total</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;width:1%" valign="bottom"> </td><td style="border-bottom:1pt solid black;text-align:right;width:9%" valign="bottom">(26,973</td><td style="width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">64,214</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">November 30, 2019</td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="text-align:right;width:9%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td></tr><tr style="background-color:#ffffff"><td valign="top">Common stock</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom">(40,972</td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 1px solid;text-align:right;width:9%" valign="bottom"> </td><td style="PADDING-BOTTOM:1px;width:1%" valign="bottom"> </td></tr><tr style="background-color:#cceeff"><td valign="top">Total</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">81,250</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">9,335</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">(67,945</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom">)</td><td style="width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;width:1%" valign="bottom"> </td><td style="BORDER-BOTTOM:black 3px double;text-align:right;width:9%" valign="bottom">22,640</td><td style="PADDING-BOTTOM:3px;width:1%" valign="bottom"> </td></tr></tbody></table></div>

81250

9335

12124

26973

40972

67945

20. Subsequent Events a) Subsequent to November 30, 2019, 110,000 options were exercised for a total of $11,000.

Options granted vest 50,000 on grant and the remainder based on contracted milestones Options granted vest 250,000 on grant and the remainder based on contracted milestones Corporate office and R lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years. C.A.B. Financial Services is owned by the CEO of the Company, M Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company. The patents are amortized over their legal life of 20 years. EX-101.SCH 7 lxrp-20191130.xsd XBRL TAXONOMY EXTENSION SCHEMA 0001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 0002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) link:presentationLink link:definitionLink link:calculationLink 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:definitionLink link:calculationLink 0006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 0007 - Disclosure - Organization, Business and Going Concern link:presentationLink link:definitionLink link:calculationLink 0008 - Disclosure - Business Risk and Liquidity link:presentationLink link:definitionLink link:calculationLink 0009 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 0010 - Disclosure - Basis of Consolidation link:presentationLink link:definitionLink link:calculationLink 0011 - Disclosure - Estimates and Judgments link:presentationLink link:definitionLink link:calculationLink 0012 - Disclosure - Recent Accounting Guidance link:presentationLink link:definitionLink link:calculationLink 0013 - Disclosure - Accounts and Other Receivables link:presentationLink link:definitionLink link:calculationLink 0014 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 0015 - Disclosure - Intellectual Property link:presentationLink link:definitionLink link:calculationLink 0016 - Disclosure - Property & Equipment link:presentationLink link:definitionLink link:calculationLink 0017 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 0018 - Disclosure - Unearned Revenue link:presentationLink link:definitionLink link:calculationLink 0019 - Disclosure - Common Shares and Warrants link:presentationLink link:definitionLink link:calculationLink 0020 - Disclosure - Stock Options link:presentationLink link:definitionLink link:calculationLink 0021 - Disclosure - Revenues link:presentationLink link:definitionLink link:calculationLink 0022 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 0023 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 0024 - Disclosure - Commitments, Significant Contracts and Contingencies link:presentationLink link:definitionLink link:calculationLink 0025 - Disclosure - Prepaid Expenses link:presentationLink link:definitionLink link:calculationLink 0026 - Disclosure - Marketable Securities link:presentationLink link:definitionLink link:calculationLink 0027 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 0028 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 0029 - Disclosure - Accounts and Other Receivables (Tables) link:presentationLink link:definitionLink link:calculationLink 0030 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 0031 - Disclosure - Intellectual Property (Tables) link:presentationLink link:definitionLink link:calculationLink 0032 - Disclosure - Property & Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 0033 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 0034 - Disclosure - Unearned Revenue (Tables) link:presentationLink link:definitionLink link:calculationLink 0035 - Disclosure - Common Shares and Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 0036 - Disclosure - Stock Options (Tables) link:presentationLink link:definitionLink link:calculationLink 0037 - Disclosure - Revenues (Tables) link:presentationLink link:definitionLink link:calculationLink 0038 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 0039 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 0040 - Disclosure - Commitments, Significant Contracts and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 0041 - Disclosure - Prepaid Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 0042 - Disclosure - Marketable Securities (Tables) link:presentationLink link:definitionLink link:calculationLink 0043 - Disclosure - Basis of Consolidation (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0044 - Disclosure - Recent Accounting Guidance (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0045 - Disclosure - Accounts and Other Receivables (Details) link:presentationLink link:definitionLink link:calculationLink 0046 - Disclosure - Inventory (Details) link:presentationLink link:definitionLink link:calculationLink 0047 - Disclosure - Inventory (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0048 - Disclosure - Intellectual Property (Details) link:presentationLink link:definitionLink link:calculationLink 0049 - Disclosure - Intellectual Property (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0050 - Disclosure - Property & Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 0051 - Disclosure - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 0052 - Disclosure - Unearned Revenue (Details) link:presentationLink link:definitionLink link:calculationLink 0053 - Disclosure - Unearned Revenue (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0054 - Disclosure - Common Shares and Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 0055 - Disclosure - Common Shares and Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 0056 - Disclosure - Common Shares and Warrants (Details 2) link:presentationLink link:definitionLink link:calculationLink 0057 - Disclosure - Common Shares and Warrants (Details 3) link:presentationLink link:definitionLink link:calculationLink 0058 - Disclosure - Common Shares and Warrants (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0059 - Disclosure - Stock Options (Details) link:presentationLink link:definitionLink link:calculationLink 0060 - Disclosure - Stock Options (Details 1) link:presentationLink link:definitionLink link:calculationLink 0061 - Disclosure - Stock Options (Details 2) link:presentationLink link:definitionLink link:calculationLink 0062 - Disclosure - Stock Options (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0063 - Disclosure - Revenues (Details) link:presentationLink link:definitionLink link:calculationLink 0064 - Disclosure - Revenues (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0065 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 0066 - Disclosure - Related Party Transactions (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0067 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 0068 - Disclosure - Segment Information (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 0069 - Disclosure - Commitments, Significant Contracts and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 0070 - Disclosure - Prepaid Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 0071 - Disclosure - Marketable Securities (Details) link:presentationLink link:definitionLink link:calculationLink 0072 - Disclosure - Subsequent Events (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 lxrp-20191130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 lxrp-20191130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 lxrp-20191130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 lxrp-20191130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 lxrp_10qimg1.jpg begin 644 lxrp_10qimg1.jpg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end XML 13 R25.htm IDEA: XBRL DOCUMENT

Marketable Securities

3 Months Ended

Nov. 30, 2019

Marketable Securities [Abstract]

Marketable Securities

19. Marketable Securities

The components of Marketable Securities were as follows:

Cost

Basis

Unrealized

Gains
$

Unrealized

Losses

Total$

August 31, 2019

Common stock

81,250

9,335

(12,124

)

Total

81,250

9,335

(26,973

)

64,214

November 30, 2019

Common stock

81,250

9,335

(40,972

)

Total

81,250

9,335

(67,945

)

22,640

XML 14 R21.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Nov. 30, 2019

Related Party Transactions

15. Related Party Transactions

	Nov 30 2019 Total $		Nov 30 2018 Total $
Management, consulting and accounting services
C.A.B Financial Services(1)		65,757		36,000
ME Services Ltd.(1)		29,382		27,422
Docherty Management Limited(1)		56,730		34,278
Directors		16,717		—
		168,586		97,700

⁽¹⁾C.A.B. Financial Services is owned by the CEO of the Company, ME Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.

Due to related parties:

As at November 30, 2019, $37,200 (August 31, 2019 - $48,096) was payable to related parties included in due to related parties.

The related party transactions are recorded at the exchange amount established and agreed to between the related parties.

XML 15 R29.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

3 Months Ended

Nov. 30, 2019

Inventory Disclosure [Abstract]

Schedule of Inventory

	November 30 2019 $		August 31 2019 $
Raw materials		58,806		45,068
Finished goods		74,750		82,328
		133,556		127,396

XML 16 R48.htm IDEA: XBRL DOCUMENT

Common Shares and Warrants (Details)	3 Months Ended
Common Shares and Warrants (Details)	Nov. 30, 2019 USD ($) shares
Common Shares And Warrants [Line Items]
Number of Shares \| shares	1,823,745
Total Value \| $	$ 820,685
Private Placement
Common Shares And Warrants [Line Items]
Number of Shares \| shares	1,823,745
Total Value \| $	$ 820,685

XML 17 R40.htm IDEA: XBRL DOCUMENT

Basis of Consolidation (Detail Textuals)	Nov. 30, 2019
Altria Ventures Inc.
Equity interest percentage	16.667%
Lexaria Nicotine LLC
Equity interest percentage	83.333%

XML 18 R44.htm IDEA: XBRL DOCUMENT

Intellectual Property (Details) - USD ($)

3 Months Ended

12 Months Ended

Nov. 30, 2019

Aug. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Balance - beginning

$ 265,127

$ 146,538

Addition

5,710

122,982

Amortization

^[1]

(1,421)

(4,393)

Balance - ending

$ 269,416

$ 265,127

[1]	The patents are amortized over their legal life of 20 years.

XML 19 R63.htm IDEA: XBRL DOCUMENT

Commitments, Significant Contracts and Contingencies (Details)

3 Months Ended

Nov. 30, 2019

CAD ($)

C.A.B Financial Services

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 29,167

Expiry Date

January 1, 2022

Docherty Management Ltd.

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 25,000

Expiry Date

January 1, 2022

M&E Services Ltd.

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 12,960

Expiry Date

June 1, 2021

Corporate development

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 1,000

Expiry Date

Month to Month

Corporate development

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 8,000

Expiry Date

Month to Month

Investor relations and communications - Alex Blanchard Capital

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 7,500

Expiry Date

Month to Month

Office management

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 10,000

Expiry Date

August 15, 2022

Research & development

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 3,854

Expiry Date

Month to Month

Office rent

Commitments Significant Contracts And Contingencies [Line Items]

Monthly Commitment

$ 4,823

^[1]

Expiry Date

November 15, 2023

^[1]

[1]	Corporate office and R lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.

XML 20 R55.htm IDEA: XBRL DOCUMENT

Stock Options (Details 2)	3 Months Ended
Stock Options (Details 2)	Nov. 30, 2019 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	96.00%
Risk-free interest rate	1.66%
Expected life	5 years
Dividend yield	0.00%
Estimated fair value per option	$ 0.39

XML 21 R51.htm IDEA: XBRL DOCUMENT

Common Shares and Warrants (Details 3) - $ / shares	3 Months Ended
Common Shares and Warrants (Details 3) - $ / shares	Nov. 30, 2019	Aug. 31, 2019	Aug. 31, 2018
Number of Warrants	4,882,820	2,825,325	3,286,274
Weighted Average Remaining Contractual Life	1 year 5 months 15 days
Weighted Average Exercise Price	$ 1.14
# of Warrants 250,000
Number of Warrants	250,000
Weighted Average Remaining Contractual Life	3 days
Weighted Average Exercise Price	$ 0.83
# of Warrants 500,000
Number of Warrants	500,000
Weighted Average Remaining Contractual Life	1 month 17 days
Weighted Average Exercise Price	$ 1.83
# of Warrants 975,325
Number of Warrants	975,325
Weighted Average Remaining Contractual Life	11 months 1 day
Weighted Average Exercise Price	$ 2.25
# of Warrants 100,000
Number of Warrants	100,000
Weighted Average Remaining Contractual Life	1 year 5 months 23 days
Weighted Average Exercise Price	$ 0.96
# of Warrants 250,000
Number of Warrants	250,000
Weighted Average Remaining Contractual Life	1 year 5 months 23 days
Weighted Average Exercise Price	$ 1.55
# of Warrants 750,000
Number of Warrants	750,000
Weighted Average Remaining Contractual Life	1 year 10 months 9 days
Weighted Average Exercise Price	$ 0.14
# of Warrants 225,000
Number of Warrants	225,000
Weighted Average Remaining Contractual Life	2 years
Weighted Average Exercise Price	$ 0.80
# of Warrants 1,832,495
Number of Warrants	1,832,495
Weighted Average Remaining Contractual Life	2 years
Weighted Average Exercise Price	$ 0.80

XML 22 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018
Income Statement [Abstract]
Revenue (Note 14)	$ 62,082	$ 22,209
Cost of Goods Sold	7,853	2,158
Gross profit	54,229	20,051
Expenses
Accounting and audit	19,036	9,572
Depreciation and Amortization (Note 8, 9)	27,512	1,603
Advertising and promotions	46,268	171,913
Consulting (Notes 12, 13, 15)	483,796	242,991
Investor relations	17,515
Legal and professional	52,355	96,652
Office and miscellaneous	74,027	72,902
Research and development	107,463	96,973
Travel	21,853	19,206
Wages & Salaries	87,593
Unrealized Loss on marketable securities (Note 19)	41,574	9,630
Total Operating Expenses	978,992	721,442
Net (loss) and comprehensive loss for the period	(924,763)	(701,391)
Net (loss) and comprehensive loss attributable to:
Common shareholders	(907,313)	$ (701,391)
Non-Controlling Interest	$ (17,450)
Basic and diluted (loss) per share (in dollars per share)	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding
-Basic and diluted (in shares)	79,097,349	76,226,802

XML 23 R59.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details) - USD ($)

3 Months Ended

Nov. 30, 2019

Nov. 30, 2018

Management, consulting and accounting services:

$ 168,586

$ 97,700

C.A.B Financial Services

Management, consulting and accounting services:

^[1]

65,757

36,000

M&E Services Ltd.

Management, consulting and accounting services:

^[1]

29,382

27,422

Docherty Management Limited

Management, consulting and accounting services:

^[1]

56,730

34,278

Directors

Management, consulting and accounting services:

$ 16,717

$ 0

[1]	C.A.B. Financial Services is owned by the CEO of the Company, M Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.

XML 24 R8.htm IDEA: XBRL DOCUMENT

Business Risk and Liquidity

3 Months Ended

Nov. 30, 2019

Business Risk And Liquidity [Abstract]

Business Risk and Liquidity

2. Business Risk and Liquidity

XML 26 R17.htm IDEA: XBRL DOCUMENT

Accounts Payable and Accrued Liabilities

3 Months Ended

Nov. 30, 2019

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

11. Accounts Payable and Accrued Liabilities

	November 30 2019 $		August 31 2019 $
Accounts Payable
Trades payable		89,254		31,463
Sales tax payable		—		63,616
Accrued Liabilities
Trades payable		3,775		41,332
Balance – Ending		93,029		136,411

XML 27 R13.htm IDEA: XBRL DOCUMENT

Accounts and Other Receivables

3 Months Ended

Nov. 30, 2019

Accounts and Financing Receivable, after Allowance for Credit Loss [Abstract]

Accounts and Other Receivables

7. Accounts and Other Receivables

	November 30 2019 $		August 31 2019 $
Trade and deposits receivable		5,458		5,727
Territory license fee receivable		124,324		106,000
Sales tax receivable		86,094		161,418
Subscription receivable		110,025		—
		325,901		273,145

XML 28 R38.htm IDEA: XBRL DOCUMENT

Prepaid Expenses (Tables)

3 Months Ended

Nov. 30, 2019

Prepaid Expense, Current [Abstract]

Schedule of prepaid expenses

	November 30 2019 $		August 31 2019 $
Advertising Conferences		54,587		39,143
Office Insurance		41,480		29,784
		96,067		68,927

EXCEL 29 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 30 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Intellectual Property (Tables)
3 Months Ended

Nov. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of patents

November 30
2019
$

August 31
2019
$

Balance – beginning

265,127

146,538

Additions

5,710

122,982

Amortization*

(1,421 )

(4,393 )
Balance – ending

269,416

265,127

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stock Options (Tables)
3 Months Ended

Nov. 30, 2019

Share-based Payment Arrangement [Abstract]

Schedule of exercise price
Quantity

Exercise Price $

Life (Years)

500,000⁽¹⁾

0.55

5

500,000⁽²⁾

0.55

5

1,000,000

0.55

__________
⁽¹⁾Options granted vest 50,000 on grant and the remainder based on contracted milestones
⁽²⁾Options granted vest 250,000 on grant and the remainder based on contracted milestones

Schedule of stock options

Options

Weighted
Average Exercise Price
$

Weighted Average Remaining Contractual Term (Years)

Aggregate
Intrinsic Value
$

Balance August 31, 2018

4,800,000

0.71

Expired/cancelled
(1,415,000
)
0.66
Exercised

(430,000 )

0.15

Granted

2,048,000

1.00

Balance August 31, 2019

5,003,000

0.89

Granted

1,000,000

0.55

Balance November 30, 2019 (Outstanding)

6,003,000

0.84

3.41

931,800

Balance November 30, 2019 (Exercisable)

4,261,341

0.88

2.94

794,300

Schedule of fair value of options granted

November 30
2019

Expected volatility

96%

Risk-free interest rate

1.66%

Expected life

5 years

Dividend yield

0.00%

Estimated fair value per option
$

0.39

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Revenues (Detail Textuals) - USD ($)
3 Months Ended

Nov. 30, 2019

Nov. 30, 2018

Disaggregation of Revenue [Line Items]

Licensing revenue $ 62,082 $ 22,209

Intellectual Property Licensing fees

Disaggregation of Revenue [Line Items]

Licensing revenue 37,750

Usage Fees

Disaggregation of Revenue [Line Items]

Licensing revenue $ 18,000 $ 19,902

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DisaggregationOfRevenueLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=lxrp_IntellectualPropertyLicensingFeesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=lxrp_UsageFeesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Significant Accounting Policies
3 Months Ended

Nov. 30, 2019

Accounting Policies [Abstract]

Significant Accounting Policies
3. Significant Accounting Policies

The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R54.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stock Options (Details 1) - USD ($)
3 Months Ended 12 Months Ended

Nov. 30, 2019

Aug. 31, 2019

Weighted Average Exercise Price

Exercise Price $ 0.55

Fiscal 2020 Activity

Options

Balance outstanding 5,003,000 4,800,000

Expired (1,415,000)

Exercised 430,000

Granted 1,000,000 2,048,000

Balance outstanding 6,003,000 5,003,000

Balance, Exercisable 4,261,341

Weighted Average Exercise Price

Balance outstanding $ 0.89 $ 0.71

Expired 0.66

Exercise Price 0.15

Granted 0.55 1.00

Balance outstanding 0.84 $ 0.89

Balance, Exercisable $ 0.88

Weighted Average Remaining Contractual Term, Outstanding 3 years 4 months 28 days

Weighted Average Remaining Contractual Term, Exercisable 2 years 11 months 8 days

Aggregate Intrinsic Value, Outstanding $ 931,800

Aggregate Intrinsic Value, Exercisable $ 794,300

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=lxrp_Fiscal2020ActivityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Document and Entity Information - shares
3 Months Ended

Nov. 30, 2019

Jan. 08, 2020

Document and Entity Information [Abstract]

Entity Registrant Name Lexaria Bioscience Corp.

Entity Central Index Key 0001348362

Current Fiscal Year End Date --08-31

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 80,720,879

Document Type 10-Q

Document Period End Date Nov. 30, 2019

Amendment Flag false

Document Fiscal Year Focus 2020

Document Fiscal Period Focus Q1

Entity Small Business true

Entity Emerging Growth Company false

Entity Current Reporting Status Yes

Entity Shell Company false

Entity Interactive Data Current Yes

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Document and Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: lxrp_DocumentAndEntityInformationAbstract

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Common Shares and Warrants (Details 2)
3 Months Ended

Nov. 30, 2019

$ / shares

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Expected volatility 96.00%

Risk-free interest rate 1.66%

Expected life 5 years

Dividend yield 0.00%

Warrant

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Expected volatility 91.00%

Risk-free interest rate 2.87%

Expected life 2 years

Dividend yield 0.00%

Warrant | Minimum

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Estimated fair value per warrant $ 0.28

Warrant | Maximum

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Estimated fair value per warrant $ 0.43

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
3 Months Ended

Nov. 30, 2019

Nov. 30, 2018

Cash flows used in operating activities

Net loss and comprehensive loss $ (924,763) $ (701,391)

Adjustments to reconcile net loss to net cash Used in operating activities:

Consulting - Stock based compensation 162,414 64,044

Depreciation and amortization 27,512 1,603

Unrealized loss on marketable securities 41,574 9,630

Warrants issued for services 70,752

Change in working capital

Accounts receivable 57,269 (5,365)

Inventory (6,160) (29,435)

Prepaid expenses and deposits (27,140) 10,302

Accounts payable and accrued liabilities (43,382) 72,499

Due to related parties (10,896) 13,799

Net cash used in operating activities (652,820) (564,314)

Cash flows used in investing activities

Patent (5,710) (44,368)

Property & Equipment (122,832)

Net cash used in investing activities (5,710) (167,200)

Cash flows from financing activities

Proceeds from issuance of equity 706,704 1,649,190

Net cash from financing activities 706,704 1,649,190

Decrease in cash and cash equivalents 48,174 917,676

Cash and cash equivalents, beginning of quarter 1,285,147 1,727,184

Cash and cash equivalents, end of quarter 1,333,321 $ 2,644,860

Supplemental information of cash flows:

Income taxes paid in cash 957

Subscription Receivable $ 110,025

X

- Definition
Information about subscription receivable.
+ References
No definition available.
+ Details

Name: lxrp_SubscriptionReceivable

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Adjustment for noncash service expenses paid for by granting of warrants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_AdjustmentOfWarrantsGrantedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInDueToRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) on investment in marketable security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7)(c))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_MarketableSecuritiesUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Property & Equipment
3 Months Ended

Nov. 30, 2019

Proceeds from Sale of Property, Plant, and Equipment [Abstract]

Property & Equipment
10. Property Equipment

Net Balance
Year Ended August 31, 2019 Cost
Period
Amortization

Accumulated
Amortization

August 31,
2019

$ $ $ $
Leasehold improvements 259,981 (33,342 ) (33,342 ) 226,639
Computers 63,964 (12,187 ) (12,187 ) 51,777
Furniture fixtures equipment 34,220 (4,205 ) (6,062 ) 28,158
Lab equipment 291,235 (6,546 ) (6,546 ) 284,689
649,400 (56,281 ) (58,137 ) 591,263

Net Balance
Quarter Ended November 30, 2019
Cost
Amortization
Period

Accumulated
Amortization
November 30,
2019
$ $ $ $
Leasehold improvements 259,981 (12,740 ) (46,082 ) 213,899
Computers 63,964 (4,920 ) (17,107 ) 46,857
Furniture fixtures equipment 34,220 (1,759 ) (7,821 ) 26,399
Lab equipment 291,235 (6,672 ) (13,218 ) 278,017
649,400 (26,091 ) (84,228 ) 565,172

X

- References
No definition available.
+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Recent Accounting Guidance
3 Months Ended

Nov. 30, 2019

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Guidance
6. Recent Accounting Guidance

In February 2016 FASB issued ASU No. 201602, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and the lessors. The new standard requires the lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right of use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2020. When adopted, the Company does not expect this guidance to have a material impact on its consolidated financial statements.

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available for sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2022. Application of the amendments is through a cumulative effect adjustment to deficit as of the effective date. The Company is currently assessing the impact of the standard on its consolidated financial statements.

In February 2018, the FASB issued ASU No. 201802, Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted by the U.S. federal government on December 22, 2017 (the “2017 Tax Act”). Consequently, the amendments eliminate the stranded tax effects resulting from the 2017 Tax Act and will improve the usefulness of information reported to financial statement users. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

In June 2018, the FASB issued ASU No. 201807, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share Based Payment Accounting. This is a simplification that involves several aspects of accounting for nonemployee share-based payments resulting from expanding the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Property & Equipment (Tables)
3 Months Ended

Nov. 30, 2019

Proceeds from Sale of Property, Plant, and Equipment [Abstract]

Schedule of property & equipment

Net Balance
Year Ended August 31, 2019 Cost
Period
Amortization

Accumulated
Amortization

August 31,
2019

$ $ $ $
Leasehold improvements 259,981 (33,342 ) (33,342 ) 226,639
Computers 63,964 (12,187 ) (12,187 ) 51,777
Furniture fixtures equipment 34,220 (4,205 ) (6,062 ) 28,158
Lab equipment 291,235 (6,546 ) (6,546 ) 284,689
649,400 (56,281 ) (58,137 ) 591,263

Net Balance
Quarter Ended November 30, 2019
Cost
Amortization
Period

Accumulated
Amortization
November 30,
2019
$ $ $ $
Leasehold improvements 259,981 (12,740 ) (46,082 ) 213,899
Computers 63,964 (4,920 ) (17,107 ) 46,857
Furniture fixtures equipment 34,220 (1,759 ) (7,821 ) 26,399
Lab equipment 291,235 (6,672 ) (13,218 ) 278,017
649,400 (26,091 ) (84,228 ) 565,172

X

- References
No definition available.
+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Revenues (Tables)
3 Months Ended

Nov. 30, 2019

Revenues [Abstract]

Schedule of revenue

November 30
2019
$

November 30
2018
$

Product sales

10,015

2,257

Licensing revenue

51,750

19,902

Freight revenue

317

50

62,082

22,209

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599
+ Details

Name: us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Marketable Securities (Tables)
3 Months Ended

Nov. 30, 2019

Marketable Securities [Abstract]

Schedule of marketable securities

Cost
Basis
$

Unrealized
Gains
$

Unrealized
Losses
$

Total$

August 31, 2019

Common stock

81,250

9,335

(12,124 )

Total

81,250

9,335

(26,973 )

64,214

November 30, 2019

Common stock

81,250

9,335

(40,972 )

Total

81,250

9,335

(67,945 )

22,640

X

- References
No definition available.
+ Details

Name: us-gaap_MarketableSecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.
+ References
No definition available.
+ Details

Name: us-gaap_MarketableSecuritiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Accounts and Other Receivables (Tables)
3 Months Ended

Nov. 30, 2019

Accounts and Financing Receivable, after Allowance for Credit Loss [Abstract]

Schedule of accounts and other receivables

November 30
2019
$

August 31
2019
$

Trade and deposits receivable

5,458

5,727

Territory license fee receivable

124,324

106,000

Sales tax receivable

86,094

161,418

Subscription receivable 110,025 —

325,901

273,145

X

- Definition
Tabular disclosure of accounts and other receivable.
+ References
No definition available.
+ Details

Name: lxrp_ScheduleOfAccountsAndOtherReceivableTableTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsAndNotesReceivableNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Prepaid Expenses
3 Months Ended

Nov. 30, 2019

Prepaid Expense, Current [Abstract]

Prepaid Expenses
18. Prepaid Expenses

 Prepaid expenses consist of the following at November 30, 2019 and August 31, 2019:

November 30
2019
$

August 31
2019
$

Advertising Conferences

54,587

39,143

Office Insurance

41,480

29,784

96,067

68,927

X

- Definition
Prepaid Expenses
+ References
No definition available.
+ Details

Name: lxrp_PrepaidExpensesTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PrepaidExpenseCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Revenues
3 Months Ended

Nov. 30, 2019

Revenues [Abstract]

Revenues
14. Revenues

November 30
2019
$

November 30
2018
$

Product sales

10,015

2,257

Licensing revenue

51,750

19,902

Freight revenue

317

50

62,082

22,209

During the period ended November 30, 2019, the Company recognized $37,750 of Intellectual Property Licensing fees and $18,000 of Usage Fees (November 2018 -$Nil and $19,902). Licensing revenues are significantly concentrated on a single customer.

There was an increase in product sales in the current year compared to the previous years as the Company was able to solve some payment processing issues late in fiscal 2019, allowing for improved ability to conduct retail transactions. The Licensing fees consist of IP licensing fees for transfer of the Technology with the signing of definitive agreements for the DehydraTECH technology and usage fees. The Licensing fees include payments due upon transfer of the Technology and installment payments that are receivable within 12 months (Note 7).

X

- Definition
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388
+ Details

Name: us-gaap_RevenueFromContractWithCustomerTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Accounts and Other Receivables (Details) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Accounts and Financing Receivable, after Allowance for Credit Loss [Abstract]

Trade and deposits receivable $ 5,458 $ 5,727

Territory license fee receivable 124,324 106,000

Sales tax receivable 86,094 161,418

Subscription receivable 110,025 0

Accounts and other receivable $ 325,901 $ 273,145

X

- Definition
Amount of subscription receivables due within one year or the normal operating cycle, if longer.
+ References
No definition available.
+ Details

Name: lxrp_SubscriptionReceivablesCurrent

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Territory License Fee receivable
+ References
No definition available.
+ Details

Name: lxrp_TerritoryLicenseFeeReceivable

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Trade and deposits receivable
+ References
No definition available.
+ Details

Name: lxrp_TradeAndDepositsReceivable

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsAndNotesReceivableNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ValueAddedTaxReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 47 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Intellectual Property (Detail Textuals)
3 Months Ended

Nov. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Useful life 20 years

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R49.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Common Shares and Warrants (Details 1) - $ / shares
3 Months Ended 12 Months Ended

Nov. 30, 2019

Aug. 31, 2019

Common Shares And Warrants [Roll Forward]

Number of Warrants, Balance 2,825,325 3,286,274

Weighted Average Exercise Price, Balance $ 1.38 $ 0.72

Number of Warrants, Cancelled/Expired (17,498)

Weighted Average Exercise Price, Cancelled/Expired $ 0.59

Number of Warrants, Exercised (1,626,513)

Weighted Average Exercise Price, Exercised $ 0.49

Number of Warrants, Issued 2,057,495 1,183,062

Weighted Average Exercise Price, Issued $ 0.80 $ 1.99

Number of Warrants, Balance 4,882,820 2,825,325

Weighted Average Exercise Price, Balance $ 1.14 $ 1.38

X

- Definition
Class of Warrant or Right, Exercises in Period
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightExercised

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Expirations in Period
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightExpirationsInPeriod

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Expirations in Period, Weighted Average Exercise Price
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Grants in Period, Net of Forfeitures
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightGrantsInPeriod

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, Beginning of Period
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: lxrp_CommonSharesAndWarrantsRollForward

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 49 R66.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Subsequent Events (Detail Textuals) - USD ($)
1 Months Ended 12 Months Ended

Jan. 02, 2020

Aug. 31, 2019

Aug. 31, 2018

Subsequent Event [Line Items]

Value of stock options exercised $ 66,250 $ 93,702

Subsequent Event

Subsequent Event [Line Items]

Number of Shares Option Exercise 110,000

Value of stock options exercised $ 11,000

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 50 R62.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Segment Information (Detail Textuals)
3 Months Ended

Nov. 30, 2019

Segment Reporting [Abstract]

Number of reportable segments 2

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 51 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares

Nov. 30, 2019

Aug. 31, 2019

Statement of Financial Position [Abstract]

Common stock, shares authorized 220,000,000 220,000,000

Common stock, par value per share (in dollars per share) $ 0.001 $ 0.001

Common stock, shares, issued 80,610,879 78,787,134

Common stock, shares, outstanding 80,610,879 78,787,134

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R56.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stock Options (Detail Textuals)
3 Months Ended

Nov. 30, 2019

shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Term of expiration 5 years

Directors Officers Employees And Consultants

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options available for grant 7,838,713

2007 Equity incentive plan | Employees And Directors

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options available for grant 412,500

2014 Stock Option Plan | Directors Officers Employees And Consultants

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options available for grant 2,107,500

2010 Stock Option Plan | Officers And Employees

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options available for grant 1,512,500

Stock Options 1

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested on grant 50,000

Stock Options 2

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested on grant 250,000

X

- Definition
Describe the approximate term of stock options expired.
+ References
No definition available.
+ Details

Name: lxrp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTermExpiration

Namespace Prefix: lxrp_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: srt_TitleOfIndividualAxis=lxrp_DirectorsOfficersEmployeesAndConsultantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=lxrp_TwoZeroZeroSevenEquityIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=lxrp_EmployeesAndDirectorsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_TwoZeroOneFourStockOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_TwoZeroOneZeroStockOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=lxrp_OfficersAndEmployeesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_StockOptionsOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_StockOptionsTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Organization, Business and Going Concern
3 Months Ended

Nov. 30, 2019

Organization, Business And Going Concern [Abstract]

Organization, Business and Going Concern 1. Organization, Business and Going Concern

Lexaria Bioscience Corp. (“Lexaria”, or the “Company”) was formed on December 9, 2004 under the laws of the State of Nevada. In March of 2014, the Company began its entry into the bioscience and alternative health and wellness business and in May 2016, the Company commenced out-licensing its patented DehydraTECH™ technology (the “Technology”) for improved delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company has its office in Kelowna, BC, Canada.

The Company’s unaudited interim consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles (US GAAP) have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for a full year.

These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated annual financial statements and notes thereto included in our annual report filed on Form 10-K for the year ended August 31, 2019.

The Company’s unaudited interim consolidated financial statements have been prepared in accordance with US GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The recurring losses from operations and net capital deficiency raise substantial doubt about the Company’s ability to continue as a going concern.

The Company requires additional funds or revenues to maintain its operations and developments. Management’s plans in this regard are to raise equity and debt financing as required, but there is no certainty that such financing will be available or that it will be available at acceptable terms. The outcome of these matters cannot be predicted at this time.

X

- References
No definition available.
+ Details

Name: lxrp_OrganizationBusinessAndGoingConcernAbstract

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Common Shares and Warrants (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended

Oct. 31, 2018

Nov. 30, 2019

Common Shares And Warrants [Line Items]

Number of units sold in private placement 1,823,745

Price per share of private placement units sold $ 0.45

Each warrant entitles to purchase common share 1

Number of common share under each unit 1

Weighted Average Exercise Price $ 1.14

Term of warrants 12 months

Warrants per exercise price $ 0.80

Proceeds for warrant exercises $ 3,937.50

Fair value of warrants issued as share issue cost $ 1,850

Number of warrant issued to broker 8,750

Warrants issued for services $ 70,752

Warrant, Exercise Price, Increase $ 1.20

Broker warrants

Common Shares And Warrants [Line Items]

Each warrant entitles to purchase common share 1

Weighted Average Exercise Price $ 0.80

Term of warrants 24 months

X

- Definition
Represents amount related to warrants exercise price.
+ References
No definition available.
+ Details

Name: lxrp_ClassOfWarrantExercisePriceOfWarrants

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: lxrp_CommonSharesAndWarrantsLineItems

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of warrants issued as share issue cost.
+ References
No definition available.
+ Details

Name: lxrp_FairValueOfWarrantsIssuedAsShareIssueCost

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of common share under each unit.
+ References
No definition available.
+ Details

Name: lxrp_NumberOfCommonShareUnderEachUnit

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of units sold in private placement.
+ References
No definition available.
+ Details

Name: lxrp_NumberOfUnitsSoldInPrivatePlacement

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Price per share of private placement units sold.
+ References
No definition available.
+ Details

Name: lxrp_PrivatePlacementPricePerUnit

Namespace Prefix: lxrp_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of warrants.
+ References
No definition available.
+ Details

Name: lxrp_TermOfWarrants

Namespace Prefix: lxrp_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants of stock issued as of the balance sheet date, including warrants that had been issued and were previously outstanding but which are now held in the treasury.
+ References
No definition available.
+ Details

Name: lxrp_WarrantsIssued

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Adjustment for noncash service expenses paid for by granting of warrants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_AdjustmentOfWarrantsGrantedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.
+ References
No definition available.
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock warrants.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromWarrantExercises

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644
+ Details

Name: us-gaap_WarrantExercisePriceIncrease

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TypeOfArrangementAxis=lxrp_BrokerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Common Shares and Warrants (Tables)
3 Months Ended

Nov. 30, 2019

Equity [Abstract]

Schedule of option and warrant exercises

Type of Issuance

Number of
Shares

Total
Value

Private placement

1,823,745

820,685

1,823,745

$ 820,685

Schedule of warrant

Number of
Warrants

Weighted Average Exercise Price
$

Balance, August 31, 2018

3,286,274

0.72

Cancelled/Expired

(17,498 )

0.59

Exercised

(1,626,513 )

0.49

Issued

1,183,062

1.99

Balance, August 31, 2019

2,825,325

1.38

Issued

2,057,495

0.80

Balance November 30, 2019

4,882,820

1.14

Schedule of warrants granted as compensation warrants by using the Black-Scholes option pricing model

November 30
2019

Expected volatility

91%

Risk-free interest rate

2.87%

Expected life

2 years

Dividend yield

0.00%

Estimated fair value per warrant

$0.28 - $0.43

Schedule of warrants outstanding

# of Warrants

Weighted Average Remaining
Contractual Life

Weighted Average
Exercise Price $

250,000

0.01 years

0.83

500,000

0.13 years

1.83

975,325

0.92 years

2.25

100,000

1.48 years

0.96

250,000

1.48 years

1.55

750,000 1.86 years 0.14
225,000 2.00 years 0.80
1,832,495
2.00 years
0.80
4,882,820

1.46 years

1.14

X

- Definition
Represents the tabular disclosure of share issuance relating to option and warrant exercises.
+ References
No definition available.
+ Details

Name: lxrp_ScheduleOfShareIssuanceIsPresentedRelatingToOptionAndWarrantExercisesTableTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of Capital Stock, Warrants [Table Text Block]
+ References
No definition available.
+ Details

Name: lxrp_ScheduleOfStockholdersEquityNoteWarrantsOrRightsActivityTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]
+ References
No definition available.
+ Details

Name: lxrp_ScheduleOfStockholdersEquityNoteWarrantsOrRightsValuationAssumptionsTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Commitments, Significant Contracts and Contingencies (Tables)
3 Months Ended

Nov. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of management and service agreements

Party

Monthly Commitment

Expiry Date

C.A.B Financial Services

CAD $29,167

January 1, 2022

Docherty Management Ltd.

CAD $25,000

January 1, 2022

ME Services Ltd.

CAD $12,960

June 1, 2021

Corporate development

CAD $1,000

Month to Month

Corporate development

CAD $8,000

Month to Month

Investor relations and communications – Alex Blanchard Capital CAD $7,500

Month to Month

Office management

CAD $10,000

August 15, 2022

Research development

CAD $3,854

Month to Month

Office rent⁽¹⁾

CAD $4,823

November 15, 2023

Corporate Offices

⁽¹⁾Corporate office and RD lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermPurchaseCommitmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 57 0001640334-20-000022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001640334-20-000022-xbrl.zip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
X?B(,US]1\ >B+;K.8UB^%OCL")IEZFJ$\4''43:)27L;D'N%8#:;=2>02V MT'O5AAJ%1+>MAM2"64<%5Z&X+ZF\DRW<;2< ;2^2Y&_(C;@CF:U1_BDO4<@NH8*,:DQ MZZCL\@KOV(SM'G&9IMW>WP1.,U1&V'T$LM6FB),Z=XX*4XL*._;DS)V24&V+ M/[E9YLGI@DY%38E:H81+PBT,*8LT!-V&*$W1THO@]XR:&FE$^N\J$&3)8LU- M0T'FC(QO[966@I!LIQ.9D+6&K5S>N"07 __'9?ST-@ PIY3\H4D@^='\%BR] M,+]./7N&F$$=H]4PI.7?NXS7'HPX=%6;F(J8/0L3(G9_DFD@NC.^B?Q/8/T( M$$^AX30W1WLA)H?7WE9(0+FDR=X';L@?62N,WWC^LQD4 M;R)R"'@AS2K'F5W#@V^OH38%)F/G/X%D%0<[8J;?R&& 5W!S!Y!/M[RE:#M1 M'F/^B_6#WM3^SKNP:NZL;@7@[K-7AX&]A7,QL,4.A\Q]7AK;_B@9:=+(L!;Y M1X=3]< 4T1"<7&Z6_9))K?!8- ;)R':P&H^,5<(ZH)V2%AU$VIST_462#?A^ M$V5G5_[N8TJ4A<@'N1F,;=K!.Z(N5C1^DMY^72$4HXN8 *L[,O MW43-:I4WZPWYRC1B*%X\+;K%4".X;-($G;4[M6/0$M G$)-C&&2>5C/#GC]S!U_3 CJP_2.FRWT*>.C&L %,@2=;)T$4&CK,%9 M0%;US'L6LB#IH9V\R_.CI8_81W"31RYNA:7P,W'=9\)>U:1:"U)6DPX^(RK= MJM3XXN-1V36/)O2Y IK@_EYC] MU-F0C!,OM**T[HK4VE-172EOO*7HWOOVB1@W!.Y0Y.QAMK>4YKNEA58RQ2L0 MT!*I2L37.EA2;;?$$/%4H9DT&T$J;*L"T;Q%XV!J:C=\FNO2316J&T:Y')A+ M]!S+,6;S_M.YT^PO8IF R_@;*P*%WW@$MYG=9*/*B0O7DZR*^Q:5OM=4L*.E M8H=]K3K[90L-/=\@E2Y3VS[9:V$2L:A-1H%4"K*+E9N,82@=./HKIM_ MR+&+P))FDSN%GG2C,G:IF4OP512,3'6S:>@<-3A*XQ<,%FEX"Q>0+%I4K_4]I"&3BXS,$AO%\Y<9^38G TFC]]CXHG1Q,Y@T M>EOB:TL)-^F(T](2O;? PX"6=;Y9;U#\E$?826D7]+)DB]-RA2E1^-7QY_2P M97VGB)R"]+R,@FOXG.4W2%G@=]*.:^(ETWF/1(1CYF]2MB^>"UGW\X MR#33B:&W:&C-6MG38]4V^A\V52^"&$-$FW^I:AL?48Q%N/$[V6*#R'ZZ3K-" M@9> F#<^+,HA;$)0)(_6!(>G9XF#5(U\8CZQU>-\/@ M.X$EM+#=C(%OA1?_"L!8T/NH0%+5$!1O$QRK3:#*M2YFM7L*M[0$5:;9D&E< M?CB92]<./=F]C)O*0X$^#;K]>%A M\J*K^U8SIK@M'11E]V9]&B6#U_JX\U[HIDM7AN^CE% .O4<89O5V;8:"Y&3A MDBXO5"FY(^AEJL"'"FZ\, Z] >P%Q^?E;6XB@ER:W;Z*_9.<'I;HSQX:(D*X M>R2,Z%Z5DI,[(C'5Q##[5U+7IEH*J%!9 MN]KK1#3*?/+.NODL5@%99K2.0N:02:G%-L<5P57\W,!)@4\V,(:50[?0- T. M]RJ$IZDZ==]L2I8%>K%CKB 1I^K8U'1MMP14SBY7Y)C:_%'>VJ@<5:O"$1=' M.]Z5%EO#?'F=2TX &\_.$L[-26-H63H"I[FE=-;+8@(+:N17#.P.ENZ4&\1L_^?'RPA^%U<& MDO:UE(IH:D;L59R4+'/.KL1=6,[5Q3&"#W.].A@'8&H=&8Q/MEN>A7F2M:O, M,JX#C9=#G-6H)T;N-:"O"J-U]A:OD")!%XMU3_26LP(C!_VL\D6\7L?1PXI MAKTH^,M#R*-7A?;"6/)'O10B5^H-C3T'50'D; >(,#Y%U,>22D9+_\, >N@E M3Q-\2&+_J\3/S^UCBX<=%9^]-?EC=@WN92]229W]\L[6:J; )W*HWX6>#Y1* M7+ [F'KIB+-V;V5>?ED_4R$)V0S>8$SLXLL4T9?%/3DY&I0E M(O=Q&%['Z)N' DT5N]+3D@ES$7H83Q<%05-T#Y>K9)HF./&B@*QS <:RKL;, M&LEW_@+T!R X(\+B+<'5,T#4=4G$TN>;^1W&U/9BZ/!U];R!*)-A?%-D"FOQ MP.AOZKE7U>\9FP_-L4T9>QQ:\B_ISD;12[OT8AO:^I@!C9'GO_3(X\=LOVPE M$O6NIJ+[%3YE;!K4A[55"+/'4T0W>^!03I$19 MTN>.IJRYNF.D:_+)M= 65 MR$W?>QO03"ABQ@PME^%DZX1NO4PS#&P2]=-87-^!;H-JBG#W F3.+SP]K;L$ M].?CLI.I_B54OQRAZF)CE##^^DIAU#!>2JA^ZR5&[H P,V(QE6A^..R(0_'5 M^JF-J_5K#Z+,G5$4+(SJR:,>?3HLF$;WP$\1=8"0!I_C")5_/?1O31K)C^;WM$0F9TW4?F^FG(TZ35S$&BT&I.L3C. Z70LI MJ[49DC;O64Y;M8VE=YAZVFIO%=ZKZ?O3MDKFT .<$ <"NN.!"!=*&*(RDC_! ML&MRY[UDI3.H=E3%(UUG*@R^>MX GZ@^?\8A&89 \W)/S@/1>='_UUW ]1[B MK]<( /H(+U&WDB%197W;UOM2E.A'.5^/.JN%)E"(,@+[^VC-?7*H2[/DZ!(^ MP8 8$38$OOKM^<12=H!9QL2>N_X_6GM+S%;1IG[M*LY]B,R$<<--J,PM&R2> MC>06.%PNV: TC3"G(D_M"&73AG0D_GF/+0[7Q@LPC83M'5_[C#=-8*>D2 V! MAJ%M;-&/Z'DV.V?[ #:$Y6%AD2,HX<-"_G9JMQ%V/LQ4OK95WV8P7>NYR&9]@?+XM%V'N(;S2I%)+( M 6Z?,?$@C1T0]#*52E@*SS3B.[G9#4U3,/L6JU&P;6@J[7 [,&FEB$*EJ:ED MPG+HZSA%:D3L6II*]-N.#)\4@=BU-)705X[\ )_52-@V-)5NMQV8UD]3I&'7 MU%0Z73GT%15Z-2HJ36WYJ?<>*U4Y77;ZD"5W6Z\YWZ;VR7H@Z#V@QP#Y0%FL M+_7"6[C@9N8I=J]YZFS/0$UOW?X2%[_%(C][J_'H,Z>V30Y9!B)7-7/K[DGY M]7J!HN<6(D).-C=#!*=J,AF[B7,$G*HQ9RR+TQ5L:D:FL<1-1]"I&[_&\C%'A8ZJ M5LRVK!WS>'*8U%"%&V:ZD\J?$DJZ-P1NZH+=%Y3*!8,Q37&TE3#;/11R6(XX MMQ]8H*][3A<5;[/$W<9L;XGV"A4X]\=[NY]4JDMC:1JLYDBF'&+G*/X*)"Z@ M:IO7\EC"YY1R.UU\B2#1A>,PN(E47QI0Z&J*RN:XV5%P!Q#]-(\\41]+J;', MXZV$\8$&N.1/.'IA"(+SERO/7]7;ZM[-ZXQMRM%7?K.R@K^0DQ#1+XKF2]9/ MVP7HD@]%U_'(F9O$:IR>-Y,U%OU4QF3PS%W.U3I;"M9\P[%/@ !OB;*;X-" MT?DNZF;,P;F-7-O!E->7/\.9B&5_N8@Q5RR5!]!W\YWQBZ#@L/D'?EN-.VZ[)?&(HB"0[,U;$4JE&3]97 M+F53J:9MF['F$]TCRKQ\T^7F173745"3] :83^R<<&?!_Z8XH13L1#PKTP:" MZQ@] /1$L!=M9&H#S"=VHF=89\9-Y"/@85&4IJC;?/+!^KW*\>$L P]G\4QL M-X"1GTL.X4[+K?B=KHLM;TKN%=0?%V&B?(= MH%M!/!UE47;+Z%9,3Y?UI773::S>^N'*X_X-K+&RZ0>_EM0N@W=*ZNM=18V+ MZBTDKU-Q[W0WOL7NP,MZ&#SQQ+?M6\!>M[JN?G^_!>Q5:^BJ+H(M6D:5]L'" M$;/'R*=YL9.B#(B-X,-+B/TPID5A,LM[NR'>@Y ^RT45,KQ7"@DK!"MV&_A8 M942!VGSUW)"5]PR"69QIB@CGKBOJE9!$0*IT'REGTC(D:@.8"D.LRK*T*@FS M<1^42*N3,!N;JE!2&UQ>I833W%2EDNKP\FHE[-:FPBUKHTNKEK!;FZI<4AU= M6KV$V5@[L'$<53LLOM_0ID1:@;KT ?5^/C16M+"$"ZTW.+N@:900_4!+CG#3 MU*?_!A[BAK%M&]0"(BT%!G16&#EVQ+'JB(ZVYQ8XJDRW@\S1LB3J;#-NUWC: MK9.)JL:0="A;X5R=?C:/'#Q, M&YX.A?;V@J=QT]--_4,%\WV;N+\2:3;]3).CH\FZH\E?@2 -"$=]%-R%7O396\O=6WU\SI0+ZIK(HQ>>OCM]=^8G M\(FHEF*O J_]6&>2AZR2(Z+SX-I.J'$X+BIER^[C,+R.$?UECPX,]@P4;/S(XIQ+]LX_VN6ZN\<]LYDZ<&0SGO%-LBX=\SVOC565[[ZW(ON M+^A1OQA2MU DQM8C,0-Q:A_KT0(LOY[;4QSL!:EHD6+KV9U7&Q6D&PHY$KCK MRHXMK-6IT*\C=MRK-?=J2Y:1.5W*$L"*%-BJY-;Z56WI^F$5=J=)_*E MQE81MJZL\M<5CU51#58+U-1*QAW0EE)98S>$(QAAZ&=)\L/LTO5OSD\M^<+, MK9"@Y M3HXYMWGWO>M#/C\16%)U]Y7.31O???> UR/T?<4'&,O?&5,H_('-#"L&P5BN M4'Z<7$5'J3$6Z^!HTAX.,HIX
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end XML 58 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Inventory
3 Months Ended

Nov. 30, 2019

Inventory Disclosure [Abstract]

Inventory
8. Inventory

November 30
2019
$

August 31
2019
$

Raw materials

58,806

45,068

Finished goods

74,750

82,328

133,556

127,396

During the period ended November 30, 2019, the Company wrote down $NIL (2019 - $7,182) of inventory to reflect its net realisable value.

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-URI http://asc.fasb.org/topic&trid=2126998
+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Basis of Consolidation
3 Months Ended

Nov. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Consolidation
4. Basis of Consolidation

These consolidated financial statements include the financial statements of the Company and its wholly owned subsidiaries; Lexaria CanPharm ULC, PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp. and Lexaria Pharmaceutical Corp., and our 83.333% subsidiary Lexaria Nicotine LLC (16.667% Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc.). All significant intercompany balances and transactions have been eliminated.

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Common Shares and Warrants
3 Months Ended

Nov. 30, 2019

Equity [Abstract]

Common Shares and Warrants
12. Common Shares and Warrants

Fiscal 2020 Activity
During the period ended November 30, 2019 the Company closed, pursuant to two tranches, a non-brokered private placement for an aggregate total of 1,823,745 Units priced at $0.45 each. Each Unit consists of one common share and one Share purchase warrant. Each warrant shall entitle the holder to acquire one common share of the Company for a period of two years at a price of $0.80 per Share until the first anniversary of issuance for a period of 12 months, and thereafter at a price of $1.20 for an additional 12 months until November 13, 2021 until the second anniversary of issuance. The Company paid $3,937.50 and issued 8,750 broker warrants. The broker warrants have a term of 24 months and are each exercisable into one common share of the Company at a price of $0.80 per Share until the first anniversary of issuance, and thereafter at a price of $1.20 until the second anniversary of issuance. The fair value of these broker warrants was determined to be $1,850, which were recorded as a share issuance cost within additional paid in capital for a net effect of $Nil.

During the period ended November 30, 2019 the Company recognized $70,752 in consulting expense for warrants granted to a consultant on vesting.

A summary of share issuance relating to option and warrant exercises, agreement requirements and debt settlement is presented below:

Type of Issuance

Number of
Shares

Total
Value

Private placement

1,823,745

820,685

1,823,745

$ 820,685

A continuity schedule for warrants is presented below:

Number of
Warrants

Weighted Average Exercise Price
$

Balance, August 31, 2018

3,286,274

0.72

Cancelled/Expired

(17,498 )

0.59

Exercised

(1,626,513 )

0.49

Issued

1,183,062

1.99

Balance, August 31, 2019

2,825,325

1.38

Issued

2,057,495

0.80

Balance November 30, 2019

4,882,820

1.14

The fair value of share purchase warrants granted as broker warrants, compensation units, and compensatory warrants, was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

November 30
2019

Expected volatility

91%

Risk-free interest rate

2.87%

Expected life

2 years

Dividend yield

0.00%

Estimated fair value per warrant

$0.28 - $0.43

A summary of warrants outstanding as of November 30, 2019 is presented below:

# of Warrants

Weighted Average Remaining
Contractual Life

Weighted Average
Exercise Price $

250,000

0.01 years

0.83

500,000

0.13 years

1.83

975,325

0.92 years

2.25

100,000

1.48 years

0.96

250,000

1.48 years

1.55

750,000 1.86 years 0.14
225,000 2.00 years 0.80
1,832,495
2.00 years
0.80
4,882,820

1.46 years

1.14

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Subsequent Events
3 Months Ended

Nov. 30, 2019

Subsequent Events [Abstract]

Subsequent Events
20. Subsequent Events

a) Subsequent to November 30, 2019, 110,000 options were exercised for a total of $11,000.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Segment Information
3 Months Ended

Nov. 30, 2019

Segment Reporting [Abstract]

Segment Information
16. Segment Information

The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on one licensee.

IP
Licensing

Consumer
Products

Corporate

Consolidated
Total

External revenue

51,750

10,332

—

62,082

CoGS

—

(7,853 )

—

(7,853 )
Operating expenses

(104,678 )

(42,020 )

(832,294 )

(978,992 )
Segment loss

(52,928 )

(39,541 )

(832,294 )

(924,763 )
Total assets

678,429

133,556

1,934,088

2,746,073

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 64 R64.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Prepaid Expenses (Details) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Prepaid Expense, Current [Abstract]

Advertising & Conferences $ 54,587 $ 39,143

Office & Insurance 41,480 29,784

Prepaid expenses and deposit (Note 18) $ 96,067 $ 68,927

X

- Definition
Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)(6)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidAdvertising

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PrepaidExpenseCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)(1)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidInsurance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 65 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Related Party Transactions (Detail Textuals) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Related Party Transactions [Abstract]

Due to a related party (Note 15) $ 37,200 $ 48,096

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 66 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Inventory (Detail Textuals)
3 Months Ended

Nov. 30, 2019

USD ($)

Inventory Disclosure [Abstract]

Inventory write-off $ 7,182

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314
+ Details

Name: us-gaap_InventoryWriteDown

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 67 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Accounts Payable and Accrued Liabilities (Details) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Accounts Payable And Accrued Liabilities[Line Items]

Accounts payable and accrued liabilities (Note 11) $ 93,029 $ 136,411

Accounts Payable

Accounts Payable And Accrued Liabilities[Line Items]

Trades payable 89,254 31,463

Sales Tax Payable 0 63,616

Accrued Liabilities

Accounts Payable And Accrued Liabilities[Line Items]

Trades payable $ 3,775 $ 41,332

X

- Definition
Represents accounts payable and accrued liabilities line item.
+ References
No definition available.
+ Details

Name: lxrp_AccountsPayableAndAccruedLiabilitiesLineItems

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765
+ Details

Name: us-gaap_AccountsPayableTradeCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_SalesAndExciseTaxPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ExtinguishmentOfDebtAxis=us-gaap_AccountsPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 68 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies (Policies)
3 Months Ended

Nov. 30, 2019

Accounting Policies [Abstract]

Significant Accounting Policies
Significant Accounting Policies

The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.

Recent Accounting Guidance
Recent Accounting Guidance

In February 2016 FASB issued ASU No. 201602, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and the lessors. The new standard requires the lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right of use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2020. When adopted, the Company does not expect this guidance to have a material impact on its consolidated financial statements.

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available for sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. In November 2019 FASB issued ASU No 201910 revised the effective date based on updated criteria with the effective date for fiscal years beginning after December 15, 2022. Application of the amendments is through a cumulative effect adjustment to deficit as of the effective date. The Company is currently assessing the impact of the standard on its consolidated financial statements.

In February 2018, the FASB issued ASU No. 201802, Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted by the U.S. federal government on December 22, 2017 (the “2017 Tax Act”). Consequently, the amendments eliminate the stranded tax effects resulting from the 2017 Tax Act and will improve the usefulness of information reported to financial statement users. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

In June 2018, the FASB issued ASU No. 201807, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share Based Payment Accounting. This is a simplification that involves several aspects of accounting for nonemployee share-based payments resulting from expanding the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the ASU on September 1, 2019 for a $NIL effect.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 69 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Commitments, Significant Contracts and Contingencies
3 Months Ended

Nov. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments, Significant Contracts and Contingencies
17. Commitments, Significant Contracts and Contingencies

Management and Service Agreements:

As at November 30, 2019, the Company is party to the following contractual commitments:

Party

Monthly Commitment

Expiry Date

C.A.B Financial Services

CAD $29,167

January 1, 2022

Docherty Management Ltd.

CAD $25,000

January 1, 2022

ME Services Ltd.

CAD $12,960

June 1, 2021

Corporate development

CAD $1,000

Month to Month

Corporate development

CAD $8,000

Month to Month

Investor relations and communications – Alex Blanchard Capital CAD $7,500

Month to Month

Office management

CAD $10,000

August 15, 2022

Research development

CAD $3,854

Month to Month

Office rent⁽¹⁾

CAD $4,823

November 15, 2023

Corporate Offices

⁽¹⁾Corporate office and RD lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 70 R65.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Marketable Securities (Details) - USD ($)
3 Months Ended 12 Months Ended

Nov. 30, 2019

Aug. 31, 2019

Marketable Securities [Line Items]

Cost Basis $ 81,250 $ 81,250

Unrealized Gains 9,335 9,335

Unrealized Losses (67,945) (26,973)

Total 22,640 64,214

Common stock

Marketable Securities [Line Items]

Cost Basis 81,250 81,250

Unrealized Gains 9,335 9,335

Unrealized Losses $ (40,972) $ (12,124)

X

- Definition
Amount of investment in marketable security, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_MarketableSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cost of investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.
+ References
No definition available.
+ Details

Name: us-gaap_TradingSecuritiesCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The increase (decrease), resulting in a gain, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period.
+ References
No definition available.
+ Details

Name: us-gaap_UnrealizedGainOnSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease), resulting in a loss, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period.
+ References
No definition available.
+ Details

Name: us-gaap_UnrealizedLossOnSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R61.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Segment Information (Details) - USD ($)
3 Months Ended

Nov. 30, 2019

Nov. 30, 2018

Aug. 31, 2019

External revenue $ 62,082 $ 22,209

CoGS (7,853) (2,158)

Operating expenses (978,992) (721,442)

Segment loss (924,763) $ (701,391)

Total assets 2,746,073 $ 2,675,219

IP Licensing

External revenue 51,750

CoGS 0

Operating expenses (104,678)

Segment loss (52,928)

Total assets 678,429

Consumer Products

External revenue 10,332

CoGS (7,853)

Operating expenses (42,020)

Segment loss (39,541)

Total assets 133,556

Corporate

External revenue 0

CoGS 0

Operating expenses (832,294)

Segment loss (832,294)

Total assets $ 1,934,088

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of income (loss) from continuing operations attributable to the parent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=lxrp_IntellectualPropertyLicensingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=lxrp_ConsumerProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Inventory (Details) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Inventory Disclosure [Abstract]

Raw materials $ 58,806 $ 45,068

Finished goods 74,750 82,328

Inventory $ 133,556 $ 127,396

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 73 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Property & Equipment (Details) - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Cost

Equipment $ 649,400 $ 649,400

Less accumulated amortization (84,228) (58,137)

Balance - Ending 565,172 591,263

Period Amortization

Cost

Less accumulated amortization (26,091) (56,281)

Leasehold Improvements

Cost

Equipment 259,981 259,981

Less accumulated amortization (46,082) (33,342)

Balance - Ending 213,899 226,639

Leasehold Improvements | Period Amortization

Cost

Less accumulated amortization (12,740) (33,342)

Computers

Cost

Equipment 63,964 63,964

Less accumulated amortization (17,107) (12,187)

Balance - Ending 46,857 51,777

Computers | Period Amortization

Cost

Less accumulated amortization (4,920) (12,187)

Furniture Fixtures Equipment

Cost

Equipment 34,220 34,220

Less accumulated amortization (7,821) (6,062)

Balance - Ending 26,399 28,158

Furniture Fixtures Equipment | Period Amortization

Cost

Less accumulated amortization (1,759) (4,205)

Lab Equipment

Cost

Equipment 291,235 291,235

Less accumulated amortization (13,218) (6,546)

Balance - Ending 278,017 284,689

Lab Equipment | Period Amortization

Cost

Less accumulated amortization $ (6,672) $ (6,546)

X

- References
No definition available.
+ Details

Name: lxrp_CostAbstract

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ChangeInAccountingEstimateByTypeAxis=lxrp_PeriodAmortizationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=lxrp_LabEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

CONSOLIDATED BALANCE SHEETS - USD ($)

Nov. 30, 2019

Aug. 31, 2019

Current

Cash and cash equivalents $ 1,333,321 $ 1,285,147

Marketable securities (Note 19) 22,640 64,214

Accounts receivable (Note 7) 325,901 273,145

Inventory (Note 8) 133,556 127,396

Prepaid expenses and deposit (Note 18) 96,067 68,927

Total Current Assets 1,911,485 1,818,829

Patent (Note 9) 269,416 265,127

Property & Equipment (Note 10) 565,172 591,263

Total Noncurrent Assets 834,588 856,390

TOTAL ASSETS 2,746,073 2,675,219

Current

Accounts payable and accrued liabilities (Note 11) 93,029 136,411

Due to a related party (Note 15) 37,200 48,096

Total Current Liabilities 130,229 184,507

TOTAL LIABILITIES 130,229 184,507

STOCKHOLDERS' EQUITY

220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 80,610,879 common shares at November 30, 2019 and 78,787,134 common shares at August 31, 2019 80,611 78,787

Additional paid-in capital (Note 12, 13) 27,220,524 26,172,453

Deficit (24,775,515) (23,868,202)

Equity attributable to shareholders of the Company 2,525,620 2,383,038

Non-Controlling Interest 90,224 107,674

Total Stockholders\' Equity 2,615,844 2,490,712

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,746,073 $ 2,675,219

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(16))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(10))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated amortization of intangible assets, excluding goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in marketable security, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 76 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Revenues (Details) - USD ($)
3 Months Ended

Nov. 30, 2019

Nov. 30, 2018

Revenue [Line Items]

Revenue $ 62,082 $ 22,209

Product sales

Revenue [Line Items]

Revenue 10,015 2,257

Licensing revenue (Note 11)

Revenue [Line Items]

Revenue 51,750 19,902

Freight revenue

Revenue [Line Items]

Revenue $ 317 $ 50

X

- Definition
Line item represents revenue.
+ References
No definition available.
+ Details

Name: lxrp_RevenueLineItems

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=us-gaap_ProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=us-gaap_LicenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=lxrp_FreightrevenueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 77 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)

COMMON STOCK

ADDITIONAL PAID-IN CAPITAL

DEFICIT

NCI

AOCI

Total

Balance at Aug. 31, 2017 $ 67,976 $ 16,108,270 $ (13,169,939) $ (238,476) $ 2,767,831

Balance (Shares) at Aug. 31, 2017 67,975,761

Shares issued for services $ 648 780,408 781,056

Shares issued for services (Shares) 647,690

Stock based compensation 2,602,239 2,602,239

Warrants issued for services 1,063,270 1,063,270

Exercise of stock options $ 546 93,156 93,702

Exercise of stock options (in shares) 545,875

Exercise of warrants $ 6,363 1,767,159 1,773,522

Exercise of warrants (in shares) 6,364,145

Net loss (6,598,843) (10,344) (6,609,187)

Non-Controlling Interest (318,820) 248,820 (70,000)

Other comprehensive income (loss) $ (14,247) (14,247)

Balance at Aug. 31, 2018 $ 75,533 22,095,682 (19,768,782) (14,247) 2,388,186

Balance (Shares) at Aug. 31, 2018 75,533,471

Shares issued for services $ 250 234,250 234,500

Shares issued for services (Shares) 250,000

Stock based compensation 626,692 626,692

Private Placement $ 947 1,469,363 1,470,310

Private Placement (in shares) 947,150

Warrants issued for services 52,817 52,817

Exercise of stock options $ 430 65,820 66,250

Exercise of stock options (in shares) 430,000

Exercise of warrants $ 1,627 794,496 796,123

Exercise of warrants (in shares) 1,626,513

Net loss (4,099,420) (4,099,420)

Non-Controlling Interest (58,993) (58,993)

Other comprehensive income (loss) $ 14,247 14,247

Subsidiary Investment 833,333 166,667 1,000,000

Balance at Aug. 31, 2019 $ 78,787 26,172,453 (23,868,202) 107,674 2,490,712

Balance (Shares) at Aug. 31, 2019 78,787,134

Stock based compensation 162,414 162,414

Private Placement $ 1,579 705,125 706,704

Private Placement (in shares) 1,579,245

Warrants issued for services 70,752 70,752

Subscription Receivable $ 245 109,780 110,025

Subscription Receivable (in shares) 244,500

Net loss (907,313) (907,313)

Non-Controlling Interest (17,450) (17,450)

Balance at Nov. 30, 2019 $ 80,611 $ 27,220,524 $ (24,775,515) $ 90,224 $ 2,615,844

Balance (Shares) at Nov. 30, 2019 80,610,879

X

- Definition
Exercise of warrants
+ References
No definition available.
+ Details

Name: lxrp_ExerciseOfWarrantsForCash

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Exercise of warrants (Shares)
+ References
No definition available.
+ Details

Name: lxrp_ExerciseOfWarrantsForCashShares

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents amount related to subsidiary investment.
+ References
No definition available.
+ Details

Name: lxrp_StockIssuedDuringPeriodThroughSubsidiaryInvestment

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Information about subscription receivable.
+ References
No definition available.
+ Details

Name: lxrp_SubscriptionReceivable

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued for subscription.
+ References
No definition available.
+ Details

Name: lxrp_SubscriptionReceivableShares

Namespace Prefix: lxrp_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrants issued for services
+ References
No definition available.
+ Details

Name: lxrp_WarrantsIssuedForService

Namespace Prefix: lxrp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 78 R53.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stock Options (Details)
3 Months Ended

Nov. 30, 2019

$ / shares

shares

Quantity | shares 1,000,000

Exercise Price | $ / shares $ 0.55

Stock Options 1

Quantity | shares 500,000 ^[1]

Exercise Price | $ / shares $ 0.55

Life (Years) 5 years

Stock Options 2

Quantity | shares 500,000 ^[2]

Exercise Price | $ / shares $ 0.55

Life (Years) 5 years

[1] Options granted vest 50,000 on grant and the remainder based on contracted milestones

[2] Options granted vest 250,000 on grant and the remainder based on contracted milestones

X

- Definition
Term of stock options.
+ References
No definition available.
+ Details

Name: lxrp_LifeYears

Namespace Prefix: lxrp_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_StockOptionsOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=lxrp_StockOptionsTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 144 284 1 true 56 0 false 5 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://lexariaenergy.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 0002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://lexariaenergy.com/role/BalanceSheet CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://lexariaenergy.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) Sheet http://lexariaenergy.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) Statements 4 false false R5.htm 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Sheet http://lexariaenergy.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Statements 5 false false R6.htm 0006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://lexariaenergy.com/role/ConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 0007 - Disclosure - Organization, Business and Going Concern Sheet http://lexariaenergy.com/role/OrganizationBusinessAndGoingConcern Organization, Business and Going Concern Notes 7 false false R8.htm 0008 - Disclosure - Business Risk and Liquidity Sheet http://lexariaenergy.com/role/BusinessRiskAndLiquidity Business Risk and Liquidity Notes 8 false false R9.htm 0009 - Disclosure - Significant Accounting Policies Sheet http://lexariaenergy.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 0010 - Disclosure - Basis of Consolidation Sheet http://lexariaenergy.com/role/BasisOfConsolidation Basis of Consolidation Notes 10 false false R11.htm 0011 - Disclosure - Estimates and Judgments Sheet http://lexariaenergy.com/role/EstimatesAndJudgments Estimates and Judgments Notes 11 false false R12.htm 0012 - Disclosure - Recent Accounting Guidance Sheet http://lexariaenergy.com/role/RecentAccountingGuidance Recent Accounting Guidance Notes 12 false false R13.htm 0013 - Disclosure - Accounts and Other Receivables Sheet http://lexariaenergy.com/role/AccountsAndOtherReceivables Accounts and Other Receivables Notes 13 false false R14.htm 0014 - Disclosure - Inventory Sheet http://lexariaenergy.com/role/Inventory Inventory Notes 14 false false R15.htm 0015 - Disclosure - Intellectual Property Sheet http://lexariaenergy.com/role/IntellectualProperty Intellectual Property Notes 15 false false R16.htm 0016 - Disclosure - Property & Equipment Sheet http://lexariaenergy.com/role/PropertyEquipment Property & Equipment Notes 16 false false R17.htm 0017 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://lexariaenergy.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 17 false false R18.htm 0019 - Disclosure - Common Shares and Warrants Sheet http://lexariaenergy.com/role/CommonSharesAndWarrants Common Shares and Warrants Notes 18 false false R19.htm 0020 - Disclosure - Stock Options Sheet http://lexariaenergy.com/role/StockOptions Stock Options Notes 19 false false R20.htm 0021 - Disclosure - Revenues Sheet http://lexariaenergy.com/role/Revenues Revenues Notes 20 false false R21.htm 0022 - Disclosure - Related Party Transactions Sheet http://lexariaenergy.com/role/RelatedPartyTransactions Related Party Transactions Notes 21 false false R22.htm 0023 - Disclosure - Segment Information Sheet http://lexariaenergy.com/role/SegmentInformation Segment Information Notes 22 false false R23.htm 0024 - Disclosure - Commitments, Significant Contracts and Contingencies Sheet http://lexariaenergy.com/role/CommitmentsSignificantContractsAndContingencies Commitments, Significant Contracts and Contingencies Notes 23 false false R24.htm 0025 - Disclosure - Prepaid Expenses Sheet http://lexariaenergy.com/role/PrepaidExpenses Prepaid Expenses Notes 24 false false R25.htm 0026 - Disclosure - Marketable Securities Sheet http://lexariaenergy.com/role/MarketableSecurities Marketable Securities Notes 25 false false R26.htm 0027 - Disclosure - Subsequent Events Sheet http://lexariaenergy.com/role/SubsequentEvents Subsequent Events Notes 26 false false R27.htm 0028 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) Policies http://lexariaenergy.com/role/SignificantAccountingPolicies 27 false false R28.htm 0029 - Disclosure - Accounts and Other Receivables (Tables) Sheet http://lexariaenergy.com/role/AccountsAndOtherReceivablesTables Accounts and Other Receivables (Tables) Tables http://lexariaenergy.com/role/AccountsAndOtherReceivables 28 false false R29.htm 0030 - Disclosure - Inventory (Tables) Sheet http://lexariaenergy.com/role/InventoryTables Inventory (Tables) Tables http://lexariaenergy.com/role/Inventory 29 false false R30.htm 0031 - Disclosure - Intellectual Property (Tables) Sheet http://lexariaenergy.com/role/IntellectualPropertyTables Intellectual Property (Tables) Tables http://lexariaenergy.com/role/IntellectualProperty 30 false false R31.htm 0032 - Disclosure - Property & Equipment (Tables) Sheet http://lexariaenergy.com/role/PropertyEquipmentTables Property & Equipment (Tables) Tables http://lexariaenergy.com/role/PropertyEquipment 31 false false R32.htm 0033 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://lexariaenergy.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://lexariaenergy.com/role/AccountsPayableAndAccruedLiabilities 32 false false R33.htm 0035 - Disclosure - Common Shares and Warrants (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Common Shares and Warrants (Tables) Tables http://lexariaenergy.com/role/CommonSharesAndWarrants 33 false false R34.htm 0036 - Disclosure - Stock Options (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock Options (Tables) Tables http://lexariaenergy.com/role/StockOptions 34 false false R35.htm 0037 - Disclosure - Revenues (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsRevenuesTextBlockTables Revenues (Tables) Tables http://lexariaenergy.com/role/Revenues 35 false false R36.htm 0038 - Disclosure - Related Party Transactions (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables Related Party Transactions (Tables) Tables http://lexariaenergy.com/role/RelatedPartyTransactions 36 false false R37.htm 0040 - Disclosure - Commitments, Significant Contracts and Contingencies (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables Commitments, Significant Contracts and Contingencies (Tables) Tables http://lexariaenergy.com/role/CommitmentsSignificantContractsAndContingencies 37 false false R38.htm 0041 - Disclosure - Prepaid Expenses (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsPrepaidExpensesTextBlockTables Prepaid Expenses (Tables) Tables http://lexariaenergy.com/role/PrepaidExpenses 38 false false R39.htm 0042 - Disclosure - Marketable Securities (Tables) Sheet http://lexariaenergy.com/role/NotesToFinancialStatementsCashCashEquivalentsAndMarketableSecuritiesTextBlockTables Marketable Securities (Tables) Tables http://lexariaenergy.com/role/MarketableSecurities 39 false false R40.htm 0043 - Disclosure - Basis of Consolidation (Detail Textuals) Sheet http://lexariaenergy.com/role/BasisOfConsolidationDetailTextuals Basis of Consolidation (Detail Textuals) Details http://lexariaenergy.com/role/BasisOfConsolidation 40 false false R41.htm 0045 - Disclosure - Accounts and Other Receivables (Details) Sheet http://lexariaenergy.com/role/AccountsAndOtherReceivablesDetails Accounts and Other Receivables (Details) Details http://lexariaenergy.com/role/AccountsAndOtherReceivablesTables 41 false false R42.htm 0046 - Disclosure - Inventory (Details) Sheet http://lexariaenergy.com/role/InventoryDetails Inventory (Details) Details http://lexariaenergy.com/role/InventoryTables 42 false false R43.htm 0047 - Disclosure - Inventory (Detail Textuals) Sheet http://lexariaenergy.com/role/InventoryDetailTextuals Inventory (Detail Textuals) Details http://lexariaenergy.com/role/InventoryTables 43 false false R44.htm 0048 - Disclosure - Intellectual Property (Details) Sheet http://lexariaenergy.com/role/IntellectualPropertyDetails Intellectual Property (Details) Details http://lexariaenergy.com/role/IntellectualPropertyTables 44 false false R45.htm 0049 - Disclosure - Intellectual Property (Detail Textuals) Sheet http://lexariaenergy.com/role/IntellectualPropertyDetailTextuals Intellectual Property (Detail Textuals) Details http://lexariaenergy.com/role/IntellectualPropertyTables 45 false false R46.htm 0050 - Disclosure - Property & Equipment (Details) Sheet http://lexariaenergy.com/role/PropertyEquipmentDetails Property & Equipment (Details) Details http://lexariaenergy.com/role/PropertyEquipmentTables 46 false false R47.htm 0051 - Disclosure - Accounts Payable and Accrued Liabilities (Details) Sheet http://lexariaenergy.com/role/AccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities (Details) Details http://lexariaenergy.com/role/AccountsPayableAndAccruedLiabilitiesTables 47 false false R48.htm 0054 - Disclosure - Common Shares and Warrants (Details) Sheet http://lexariaenergy.com/role/CommonSharesandWarrantsDetails Common Shares and Warrants (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 48 false false R49.htm 0055 - Disclosure - Common Shares and Warrants (Details 1) Sheet http://lexariaenergy.com/role/CommonSharesAndWarrantsDetails1 Common Shares and Warrants (Details 1) Details http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 49 false false R50.htm 0056 - Disclosure - Common Shares and Warrants (Details 2) Sheet http://lexariaenergy.com/role/CommonSharesAndWarrantsDetails2 Common Shares and Warrants (Details 2) Details http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 50 false false R51.htm 0057 - Disclosure - Common Shares and Warrants (Details 3) Sheet http://lexariaenergy.com/role/CommonSharesAndWarrantsDetails3 Common Shares and Warrants (Details 3) Details http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 51 false false R52.htm 0058 - Disclosure - Common Shares and Warrants (Detail Textuals) Sheet http://lexariaenergy.com/role/CommonSharesAndWarrantsDetailTextuals Common Shares and Warrants (Detail Textuals) Details http://lexariaenergy.com/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 52 false false R53.htm 0059 - Disclosure - Stock Options (Details) Sheet http://lexariaenergy.com/role/StockOptionsDetails Stock Options (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 53 false false R54.htm 0060 - Disclosure - Stock Options (Details 1) Sheet http://lexariaenergy.com/role/StockOptionsDetails1 Stock Options (Details 1) Details http://lexariaenergy.com/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 54 false false R55.htm 0061 - Disclosure - Stock Options (Details 2) Sheet http://lexariaenergy.com/role/StockOptionsDetails2 Stock Options (Details 2) Details http://lexariaenergy.com/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 55 false false R56.htm 0062 - Disclosure - Stock Options (Detail Textuals) Sheet http://lexariaenergy.com/role/StockOptionsDetailTextuals Stock Options (Detail Textuals) Details http://lexariaenergy.com/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 56 false false R57.htm 0063 - Disclosure - Revenues (Details) Sheet http://lexariaenergy.com/role/RevenuesDetails Revenues (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsRevenuesTextBlockTables 57 false false R58.htm 0064 - Disclosure - Revenues (Detail Textuals) Sheet http://lexariaenergy.com/role/RevenuesDetailTextuals Revenues (Detail Textuals) Details http://lexariaenergy.com/role/NotesToFinancialStatementsRevenuesTextBlockTables 58 false false R59.htm 0065 - Disclosure - Related Party Transactions (Details) Sheet http://lexariaenergy.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables 59 false false R60.htm 0066 - Disclosure - Related Party Transactions (Detail Textuals) Sheet http://lexariaenergy.com/role/RelatedPartyTransactionsDetailTextuals Related Party Transactions (Detail Textuals) Details http://lexariaenergy.com/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables 60 false false R61.htm 0067 - Disclosure - Segment Information (Details) Sheet http://lexariaenergy.com/role/SegmentInformationDetails Segment Information (Details) Details http://lexariaenergy.com/role/SegmentInformation 61 false false R62.htm 0068 - Disclosure - Segment Information (Detail Textuals) Sheet http://lexariaenergy.com/role/SegmentInformationDetailTextuals Segment Information (Detail Textuals) Details http://lexariaenergy.com/role/SegmentInformation 62 false false R63.htm 0069 - Disclosure - Commitments, Significant Contracts and Contingencies (Details) Sheet http://lexariaenergy.com/role/CommitmentsSignificantContractsAndContingenciesDetails Commitments, Significant Contracts and Contingencies (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables 63 false false R64.htm 0070 - Disclosure - Prepaid Expenses (Details) Sheet http://lexariaenergy.com/role/PrepaidExpensesDetails Prepaid Expenses (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsPrepaidExpensesTextBlockTables 64 false false R65.htm 0071 - Disclosure - Marketable Securities (Details) Sheet http://lexariaenergy.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://lexariaenergy.com/role/NotesToFinancialStatementsCashCashEquivalentsAndMarketableSecuritiesTextBlockTables 65 false false R66.htm 0072 - Disclosure - Subsequent Events (Detail Textuals) Sheet http://lexariaenergy.com/role/SubsequentEventsDetailTextuals Subsequent Events (Detail Textuals) Details http://lexariaenergy.com/role/SubsequentEvents 66 false false All Reports Book All Reports lxrp-20191130.xml lxrp-20191130.xsd lxrp-20191130_cal.xml lxrp-20191130_def.xml lxrp-20191130_lab.xml lxrp-20191130_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 80 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Accounts Payable and Accrued Liabilities (Tables)
3 Months Ended

Nov. 30, 2019

Payables and Accruals [Abstract]

Schedule of accounts payable and accrued liabilities

November 30
2019
$

August 31
2019
$

Accounts Payable

 Trades payable

89,254

31,463

 Sales tax payable

—

63,616

Accrued Liabilities

 Trades payable 3,775 41,332
Balance – Ending

93,029

136,411

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 81 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Related Party Transactions (Tables)
3 Months Ended

Nov. 30, 2019

Related Party Transactions [Abstract]

Schedule of related party transactions

Nov 30
2019
Total
$

Nov 30
2018
Total
$

Management, consulting and accounting services

C.A.B Financial Services(1)

65,757

36,000

ME Services Ltd.(1)

29,382

27,422

Docherty Management Limited(1)

56,730

34,278

Directors

16,717

—

168,586

97,700

⁽¹⁾C.A.B. Financial Services is owned by the CEO of the Company, ME Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 82 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stock Options
3 Months Ended

Nov. 30, 2019

Share-based Payment Arrangement [Abstract]

Stock Options
13. Stock Options

The Company has established its 2007 Equity Incentive Plan, whereby the board of directors may grant up to 412,500 stock options to eligible employees and directors, the 2010 Stock Option Plan whereby the board of directors may, from time to time, grant up to 1,512,500 stock options to officers and employees; the 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 2,107,500 stock options to directors, officers, employees, and consultants; and the 2019 Equity Incentive Plan whereby the board of directors may, from time to time, grant up to 7,838,713 stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors.

Fiscal 2020 Activity

The Company granted in the period ending November 30, 2019:

Quantity

Exercise Price $

Life (Years)

500,000⁽¹⁾

0.55

5

500,000⁽²⁾

0.55

5

1,000,000

0.55

__________
⁽¹⁾Options granted vest 50,000 on grant and the remainder based on contracted milestones
⁽²⁾Options granted vest 250,000 on grant and the remainder based on contracted milestones

A continuity schedule for stock options is presented below:

Options

Weighted
Average Exercise Price
$

Weighted Average Remaining Contractual Term (Years)

Aggregate
Intrinsic Value
$

Balance August 31, 2018

4,800,000

0.71

Expired/cancelled
(1,415,000
)
0.66
Exercised

(430,000 )

0.15

Granted

2,048,000

1.00

Balance August 31, 2019

5,003,000

0.89

Granted

1,000,000

0.55

Balance November 30, 2019 (Outstanding)

6,003,000

0.84

3.41

931,800

Balance November 30, 2019 (Exercisable)

4,261,341

0.88

2.94

794,300

The fair value of options granted was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

November 30
2019

Expected volatility

96%

Risk-free interest rate

1.66%

Expected life

5 years

Dividend yield

0.00%

Estimated fair value per option
$

0.39

X

- Definition
The entire disclosure for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 83 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Intellectual Property
3 Months Ended

Nov. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intellectual Property
9. Intellectual Property

The following is a list of US capitalized patents held by the Company

Issued Patent #
Patent Issuance Date
Patent Family
US 9,474,725 B1
10/25/2016

Food and Beverage Compositions Infused With

Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2
12/12/2017
US 9,972,680 B2
05/15/2018
US 9,974,739 B2
05/22/2018
US 10,084,044 B2
09/25/2018
US 10,103,225 B2
10/16/2018
US 10,381,440
08/13/2019
US 10,374,036
08/06/2019

The Company also holds non-capitalized patents outside the US. A continuity schedule for capitalized patents is presented below:

November 30
2019
$

August 31
2019
$

Balance – beginning

265,127

146,538

Additions

5,710

122,982

Amortization*

(1,421 )

(4,393 )
Balance – ending

269,416

265,127

* The patents are amortized over their legal life of 20 years.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 84 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Estimates and Judgments
3 Months Ended

Nov. 30, 2019

Estimates And Judgments [Abstract]

Estimates and Judgments
5. Estimates and Judgments

The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company’s accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.

The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.

In preparing these unaudited interim consolidated financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended August 31, 2019.

X

- References
No definition available.
+ Details

Name: lxrp_EstimatesAndJudgmentsAbstract

Namespace Prefix: lxrp_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Estimates and Judgments
+ References
No definition available.
+ Details

Name: lxrp_EstimatesAndJudgmentsTextBlock

Namespace Prefix: lxrp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Title of Each Class		Name of Each Exchange On Which Registered
N/A		N/A

Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨	Smaller reporting company	x
		Emerging growth company	¨

PART I—FINANCIAL INFORMATION.

Item 1.	Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	15
Item 3.	Controls and Procedures.	20

PART II—OTHER INFORMATION.

Item 1.	Legal Proceedings.	22
Item 1A.	Risk Factors.	22
Item 15.	Exhibits, Financial Statement Schedules.	23

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED BALANCE SHEET
(Expressed in U.S. Dollars)

	November 30			August 31
	2019			2019
ASSETS	(UnAudited)			(Audited)
Current
Cash and cash equivalents	$	1,333,321		$	1,285,147
Marketable Securities (Note 19)		22,640			64,214
Accounts receivable (Note 7)		325,901			273,145
Inventory (Note 8)		133,556			127,396
Prepaid expenses and deposit (Note 18)		96,067			68,927
Total Current Assets		1,911,485			1,818,829

Capital assets, net
Patent (Note 9)		269,416			265,127
Property & Equipment (Note 10)		565,172			591,263
		834,588			856,390
TOTAL ASSETS	$	2,746,073		$	2,675,219

LIABILITIES
Current
Accounts payable and accrued liabilities (Note 11)	$	93,029		$	136,411
Due to a related party (Note 15)		37,200			48,096
Total Current Liabilities		130,229			184,507
TOTAL LIABILITIES		130,229			184,507

STOCKHOLDERS' EQUITY
Share Capital (Note 12)
Authorized:
220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 80,610,879 common shares at November 30, 2019 and 78,787,134 common shares at August 31, 2019		80,611			78,787
Additional paid-in capital (Note 12, 13)		27,220,524			26,172,453
Deficit		(24,775,515	)		(23,868,202	)
Equity attributable to shareholders of the Company		2,525,620			2,383,038
Non-Controlling Interest		90,224			107,674
Total Stockholders' Equity		2,615,844			2,490,712
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	2,746,073		$	2,675,219

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Expressed in U.S. Dollars, except number of shares)

LEXARIA BIOSCIENCE CORP.
CONSOLIDATED STATEMENT OF CASH FLOWS
(Expressed in U.S. Dollars)

	COMMON STOCK
	SHARES		AMOUNT $		ADDITIONAL PAID-IN CAPITAL $			DEFICIT $			NCI $			AOCI $			STOCKHOLDERS’ EQUITY $
Balance August 31, 2017		67,975761		67,976		16,108,270			(13,169,939	)		(238,476	)		-			2,767,831
Non-controlling interest		-		-		(318,820	)		-			248,820			-			(70,000	)
Shares issued for services		647,690		648		780,408			-			-			-			781,056
Stock based compensation		-		-		2,602,239			-			-			-			2,602,239
Warrants issued for services		-		-		1,063,270			-			-			-			1,063,270
Exercise of stock options		545,875		546		93,156			-			-			-			93,702
Exercise of warrants		6,364,145		6,363		1,767,159			-			-			-			1,773,522
Net loss		-		-		-			(6,598,843	)		(10,344	)		-			(6,609,187	)
Other comprehensive loss		-		-		-			-			-			(14,247	)		(14,247	)
Balance August 31, 2018		75,533,471		75,533		22,095,682			(19,768,782	)		-			(14,247	)		2,388,186
Shares issued for services		250,000		250		234,250			-			-			-			234,500
Stock based compensation		-		-		626,692			-			-			-			626,692
Warrants issued for services		-		-		52,817			-			-			-			52,817
Exercise of stock options		430,000		430		65,820			-			-			-			66,250
Exercise of warrants		1,626,513		1,627		794,496			-			-			-			796,123
Private Placement		947,150		947		1,469,363			-			-			-			1,470,310
Net loss		-		-		-			(4,099,420	)		-			-			(4,099,420	)
Non-controlling interest		-		-		-			-			(58,993	)		-			(58,993	)
Other comprehensive income		-		-		-			-			-			14,247			14,247
Subsidiary Investment		-		-		833,333			-			166,667			-			1,000,000
Balance August 31, 2019		78,787,134		78,787		26,172,453			(23,868,202	)		107,674			-			2,490,712
Stock based compensation		-		-		162,414			-			-			-			162,414
Warrants issued for services		-		-		70,752			-			-			-			70,752
Private Placement		1,579,245		1,579		705,125			-			-			-			706,704
Subscription Receivable		244,500		245		109,780			-			-			-			110,025
Net loss		-		-		-			(907,313	)		-			-			(907,313	)
Non-controlling interest		-		-		-			-			(17,450	)		-			(17,450	)
Balance November 30, 2019		80,610,879		80,611		27,220,524			(24,775,515	)		90,224			-			2,615,844

									Net Balance
Year Ended August 31, 2019	Cost		Period Amortization			Accumulated Amortization			August 31, 2019
	$		$			$			$
Leasehold improvements		259,981		(33,342	)		(33,342	)		226,639
Computers		63,964		(12,187	)		(12,187	)		51,777
Furniture fixtures equipment		34,220		(4,205	)		(6,062	)		28,158
Lab equipment		291,235		(6,546	)		(6,546	)		284,689
		649,400		(56,281	)		(58,137	)		591,263

	IP Licensing			Consumer Products			Corporate			Consolidated Total
External revenue	$	51,750		$	10,332		$	-		$	62,082
CoGS	$	-		$	(7,853	)	$	-		$	(7,853	)
Operating expenses	$	(104,678	)	$	(42,020	)	$	(832,294	)	$	(978,992	)
Segment loss	$	(52,928	)	$	(39,541	)	$	(832,294	)	$	(924,763	)
Total assets	$	678,429		$	133,556		$	1,934,088		$	2,746,073

	PERIOD ENDED			PERIOD ENDED
	November 30			November 30
	2019			2018			Change
Revenue	$	62,082		$	22,209		$	39,873
General and administrative		978,992			721,442			257,550
Consulting fees & Employees		571,389			242,991			328,398
Legal and professional		52,355			96,652			(44,297	)
Net Loss	$	(924,763	)	$	(701,391	)	$	(223,372	)

*Working Capital*	November 30 2019			August 31 2019

Current assets	$	1,911,485		$	1,818,829
Current liabilities	$	(130,229	)	$	(184,507	)
Net Working Capital	$	1,781,256		$	1,634,322

	November 30			November 30
*Cash Flows*	2019				2018

Cash flows (used in) provided by operating activities	$	(762,845	)	$	(564,314	)
Cash flows (used in) provided by investing activities	$	(5,710	)	$	(167,200	)
Cash flows provided by financing activities	$	816,729		$	1,649,190
Decrease in cash	$	48,174		$	917,676

a)	Financial Statements

	1)	Financial statements for our Company are listed in the index under Item 8 of this document

	2)	All financial statement schedules are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto.

b)	Exhibits

By:	/s/ Christopher Bunka
	Christopher Bunka
	Chief Executive Officer, Chairman and Director
	(Principal Executive Officer)
Date:	January 8, 2020

1.	I have reviewed this Quarterly Report on Form 10-Q of Lexaria Bioscience Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's first fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

(1)	the Quarterly Report on Form 10-Q of Lexaria Bioscience Corp. for the quarter ended November 30, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lexaria Bioscience Corp.

Revenues (Detail Textuals) - USD ($)	3 Months Ended
Revenues (Detail Textuals) - USD ($)	Nov. 30, 2019	Nov. 30, 2018
Disaggregation of Revenue [Line Items]
Licensing revenue	$ 62,082	$ 22,209
Intellectual Property Licensing fees
Disaggregation of Revenue [Line Items]
Licensing revenue	37,750
Usage Fees
Disaggregation of Revenue [Line Items]
Licensing revenue	$ 18,000	$ 19,902

Significant Accounting Policies	3 Months Ended
Significant Accounting Policies	Nov. 30, 2019
Accounting Policies [Abstract]
Significant Accounting Policies	3. Significant Accounting Policies The significant accounting policies of the Company are consistent with those of our audited financial statements on Form 10-K for the year ended August 31, 2019.

Stock Options (Details 1) - USD ($)	3 Months Ended	12 Months Ended
Stock Options (Details 1) - USD ($)	Nov. 30, 2019	Aug. 31, 2019
Weighted Average Exercise Price
Exercise Price	$ 0.55
Fiscal 2020 Activity
Options
Balance outstanding	5,003,000	4,800,000
Expired		(1,415,000)
Exercised		430,000
Granted	1,000,000	2,048,000
Balance outstanding	6,003,000	5,003,000
Balance, Exercisable	4,261,341
Weighted Average Exercise Price
Balance outstanding	$ 0.89	$ 0.71
Expired		0.66
Exercise Price		0.15
Granted	0.55	1.00
Balance outstanding	0.84	$ 0.89
Balance, Exercisable	$ 0.88
Weighted Average Remaining Contractual Term, Outstanding	3 years 4 months 28 days
Weighted Average Remaining Contractual Term, Exercisable	2 years 11 months 8 days
Aggregate Intrinsic Value, Outstanding	$ 931,800
Aggregate Intrinsic Value, Exercisable	$ 794,300

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Nov. 30, 2019	Jan. 08, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Lexaria Bioscience Corp.
Entity Central Index Key	0001348362
Current Fiscal Year End Date	--08-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		80,720,879
Document Type	10-Q
Document Period End Date	Nov. 30, 2019
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Interactive Data Current	Yes

Common Shares and Warrants (Details 2)	3 Months Ended
Common Shares and Warrants (Details 2)	Nov. 30, 2019 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	96.00%
Risk-free interest rate	1.66%
Expected life	5 years
Dividend yield	0.00%
Warrant
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	91.00%
Risk-free interest rate	2.87%
Expected life	2 years
Dividend yield	0.00%
Warrant \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Estimated fair value per warrant	$ 0.28
Warrant \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Estimated fair value per warrant	$ 0.43

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018
Cash flows used in operating activities
Net loss and comprehensive loss	$ (924,763)	$ (701,391)
Adjustments to reconcile net loss to net cash Used in operating activities:
Consulting - Stock based compensation	162,414	64,044
Depreciation and amortization	27,512	1,603
Unrealized loss on marketable securities	41,574	9,630
Warrants issued for services	70,752
Change in working capital
Accounts receivable	57,269	(5,365)
Inventory	(6,160)	(29,435)
Prepaid expenses and deposits	(27,140)	10,302
Accounts payable and accrued liabilities	(43,382)	72,499
Due to related parties	(10,896)	13,799
Net cash used in operating activities	(652,820)	(564,314)
Cash flows used in investing activities
Patent	(5,710)	(44,368)
Property & Equipment		(122,832)
Net cash used in investing activities	(5,710)	(167,200)
Cash flows from financing activities
Proceeds from issuance of equity	706,704	1,649,190
Net cash from financing activities	706,704	1,649,190
Decrease in cash and cash equivalents	48,174	917,676
Cash and cash equivalents, beginning of quarter	1,285,147	1,727,184
Cash and cash equivalents, end of quarter	1,333,321	$ 2,644,860
Supplemental information of cash flows:
Income taxes paid in cash	957
Subscription Receivable	$ 110,025

Accounts and Other Receivables (Details) - USD ($)	Nov. 30, 2019	Aug. 31, 2019
Accounts and Financing Receivable, after Allowance for Credit Loss [Abstract]
Trade and deposits receivable	$ 5,458	$ 5,727
Territory license fee receivable	124,324	106,000
Sales tax receivable	86,094	161,418
Subscription receivable	110,025	0
Accounts and other receivable	$ 325,901	$ 273,145

Intellectual Property (Detail Textuals)	3 Months Ended
Intellectual Property (Detail Textuals)	Nov. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Useful life	20 years

Common Shares and Warrants (Details 1) - $ / shares	3 Months Ended	12 Months Ended
Common Shares and Warrants (Details 1) - $ / shares	Nov. 30, 2019	Aug. 31, 2019
Common Shares And Warrants [Roll Forward]
Number of Warrants, Balance	2,825,325	3,286,274
Weighted Average Exercise Price, Balance	$ 1.38	$ 0.72
Number of Warrants, Cancelled/Expired		(17,498)
Weighted Average Exercise Price, Cancelled/Expired		$ 0.59
Number of Warrants, Exercised		(1,626,513)
Weighted Average Exercise Price, Exercised		$ 0.49
Number of Warrants, Issued	2,057,495	1,183,062
Weighted Average Exercise Price, Issued	$ 0.80	$ 1.99
Number of Warrants, Balance	4,882,820	2,825,325
Weighted Average Exercise Price, Balance	$ 1.14	$ 1.38

Subsequent Events (Detail Textuals) - USD ($)	1 Months Ended	12 Months Ended
Subsequent Events (Detail Textuals) - USD ($)	Jan. 02, 2020	Aug. 31, 2019	Aug. 31, 2018
Subsequent Event [Line Items]
Value of stock options exercised		$ 66,250	$ 93,702
Subsequent Event
Subsequent Event [Line Items]
Number of Shares Option Exercise	110,000
Value of stock options exercised	$ 11,000

Segment Information (Detail Textuals)	3 Months Ended
Segment Information (Detail Textuals)	Nov. 30, 2019
Segment Reporting [Abstract]
Number of reportable segments	2